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                                                                                            Summary 
 
Chronic stress has been recognized to represent a key factor for the development 
of depression. Among others cortisol has been described to mediate an adaptive 
effect on plasma membrane fluidity which may affect signal transduction of 
membrane-bound receptors and contribute to pathophysiological changes 
leading to depression. 
Membrane fluidity can be measured by fluorescence anisotropy using DPH (1,6-
diphenyl-1,3,5-hexatriene) and TMA-DPH (1-(4-(trimethylamino)phenyl)-6-
phenylhexa-1,3,5-triene). While chronic incubation (6-8 days) with terbutaline or 
dobutamine did not affect membrane fluidity of C6 cells, chronic exposure to 
cortisol dose-dependently decreased DPH and TMA-DPH fluorescence 
anisotropy, reflecting an increase in membrane fluidity. In contrast, cells 
pretreated with St. John’s wort extract Ze117 showed increased DPH and TMA-
DPH fluorescence anisotropy values, indicating a membrane rigidification effect 
which was mediated at least by the constituents hypericin, hyperforin, quercetin, 
amentoflavone and biapigenin. Rutin showed no effect. The tricyclic 
antidepressant desipramine (DMI) also showed to expose an adaptive decrease 
in membrane fluidity, however, only in the membrane core as measured by 
increased DPH fluorescence anisotropy. Chronic incubation with citalopram on 
the other side exposed no impact on membrane fluidity. Therefore it can be 
assumed that Ze117, and in part DMI, have a “normalizing” effect on the 
membrane fluidity of "stressed" cells.  
Focusing on underlying lipidomic changes a decrease of the phosphatidylcholine 
to phosphatidylethanolamine (PC/PE) ratio was found in whole cell lipid extracts 
after chronic cortisol and Ze117 exposure which resulted at least in part from a 
decreased PC de-novo synthesis. In contrast to cortisol, which mediated a 
nonsignificant small decreased incorporation of choline-D9 into all main PC 
species under investigation, chronic Ze117 incubation selectively inhibited the 
synthesis of PC species bearing saturated or monounsaturated fatty acids.  
Citalopram and DMI had no impact on the PC/PE ratio and the choline-D9 
incorporation rate.    
  
  
 
                                                                            Zusammenfassung  
 
Mittlerweile gilt es als erwiesen, dass dauerhafter Stress eine maßgebende 
Rolle bei der Entstehung von Depression spielt. Unter anderem wurde für 
Cortisol ein adaptiver Effekt auf die Membranfluidität nachgewiesen. Diese 
Veränderung der Membranfluidität dereguliert möglicherweise die 
Signaltransduktion membrangebundener Rezeptoren und bewirkt hierbei 
pathophysiologische Veränderungen, die zur Manifestierung einer Depression 
führen.  
Die Membranfluidität kann unter anderem mittels DPH (1,6-diphenyl-1,3,5-
hexatriene) und TMA-DPH (1-(4-(trimethylamino)phenyl)-6-phenylhexa-1,3,5-
triene) Fluoreszenzanisotropie gemessen werden. Nach chronischer Inkubation 
(6-8 Tage) mit Terbutalin und Dobutamin wurden keine Veränderung in der 
Membranfluidität von C6 Zellen nachgewiesen. Nach chronischer Inkubation mit 
Cortisol jedoch wurde ein dosisabhängiger Abfall in der DPH sowie der TMA-
DPH Fluoreszenzanisotropie gefunden und somit eine gesteigerte 
Membranfluidität. Gegensätzlich führte eine chronische Inkubation mit Ze117 
im Vergleich zur Kontrolle zu einem dosisabhängigen Anstieg der DPH und 
TMA-DPH Fluoreszenzanisotropie. Dieser Effekt konnte unter anderem den 
Inhaltsstoffen Hypericin, Hyperforin, Amentoflavon, Biapigenin und Quercetin  
zugeschrieben werden. Das trizyklische Antidepressivum Desipramin (DMI) 
zeigte ebenfalls eine adaptive Versteifung der Plasmamembran, jedoch nur 
innerhalb des hydrophoben Membrankerns, da ein selektiver Anstieg der 
Fluoreszenzanisotropie nur unter Verwendung von DPH zu beobachten war. 
Citalopram zeigte keinen Einfluss. Daher könnte Ze117 und zum Teil auch DMI 
einen „normalisierenden“ Einfluss auf die Membranfluidität “gestresster“ Zellen 
haben.  
Parallel ausgeführte Lipiduntersuchungen in C6 Ganzzell-Lipidextrakten 
zeigten eine Abnahme im Phosphatidylcholin zu Phosphatidylethanolamin 
(PC/PE) Verhältnis nach chronischer Behandlung mit Ze117 und Cortisol. Diese 
Effekte sind zumindest  teilweise auf eine Abnahme der PC de-novo 
Biosynthese zurück zu führen. Hierbei wurde für Cortisol ein kleiner aber nicht 
signifikanter Abfall in der Choline-D9 Inkorporationsrate in allen hauptsächlich 
vorkommenden PC-Spezies festgestellt. Hingegen führte Ze117 zu einer 
  
 
selektiven Inhibierung der Synthese von gesättigten und einfach ungesättigten 
Fettsäuren tragenden PC-Spezies. Citalopram und DMI hatten keinen Einfluss 
auf das PC/PE Verhältnis und die Choline-D9 Inkorporationsrate.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
                                                                        List of Abbreviations 
  
 
II Parallel   
⊥ Perpendicular 
ʎem Wavelength of emitted light 
ʎex Wavelength of exited light  
β1-AR β1-adrenergic receptor 
β2-AR β2-adrenergic receptor 
ACS Acyl-CoA synthetase 
BBB Blood-brain barrier 
Bkg Background 
C6 C6 rat glioblastoma 
CCT CTP:phosphocholine cytidylyltransferase 
CK Choline kinase 
CoA Coenzyme A 
cPLA2 Cytosolic phospholipase A2 
CPT Cholinephosphotransferase 
D Deuterium  
DAG Diacylglycerol 
DHA Docosahexaenoic acid 
DMEM/F-12 Dulbecco`s modified Eagle medium 
DMI Desipramine 
DMSO Dimethyl sulfoxide 
DPH 1,6-diphenyl-1,3,5-hexatriene  
DSMZ German collection of microorganisms and cell cultures 
ECT Electroconvulsive therapy  
EDTA Ethylenediaminetetraacetic acid 
EPA Eicosapentaenoic acid 
ESI Electrospray ionization 
FBS Fetal bovine serum 
GPAT Glycerol-3-phosphate acyltransferase 
GPCR G protein-coupled receptor 
HBSS Hank´s balanced salt solution 
  
  
 
HPA Hypothalamic-pituitary-adrenal  
HPLC High performance liquid chromatography 
HPTLC High performance thin layer chromatography 
LPCAT Lysophocholine acyltransferase 
LPLAT Lysophospholipid acyltransferase 
m/z Mass-to-charge ratio 
MS Mass spectrometry 
MβCD Methyl-β-cyclodextrin  
PC Phosphatidylcholine 
PDL Poly-D-lysine 
PE Phosphatidylethanolamine 
PI Phosphatidylinositol 
PKC Protein kinase C 
PLA2 Phospholipase A2 
PTSD Posttraumatic stress disorder 
PUFA Polyunsaturated fatty acid  
r Anisotropy  
R2 Coefficient of determination  
RT Room temperature 
SEM Standard error of the mean 
SM Sphingomyelin 
SSRI Selective serotonine reuptake inhibitor 
TCA Tricyclic antidepressant 
TLC Thin layer chromatography 
TMA-DPH 1-(4-(trimethylamino)phenyl)-6-phenylhexa-1,3,5-
triene 
UV Ultraviolet  
v/v Volume per volume 
WHO World Health Organisation 
x g Units of gravity  
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1 Introduction 
1.1 Depression and treatment approaches 
Depressive disorders are dramatically disabling and potentially life-threatening 
diseases that are estimated to affect up to 20% of the population worldwide 
(Berton & Nestler, 2006; Charney & Manji, 2004; DGPPN et al., 2015; Wong & 
Licinio, 2001).  
Therefore, depression belongs to the most frequent psychiatric disorders and 
represent a leading cause of disability, according to the WHO (Reddy, 2010; Hay, 
2017; Davis et al., 2017).  
For the treatment of depressive disorders psychotherapy, antidepressant 
medication, and in severe cases electroconvulsive therapy (ECT) are applied 
dependent on the individual assessed risk-benefit profile (Fava & Kendler, 2000; 
DGPPN et al., 2015). Standard antidepressant medication include for example 
selective serotonin reuptake inhibitors (SSRI), tricyclic antidepressants (TCA) 
and alternatively to synthetic antidepressants herbal medical products. Under 
these Hypericum perforatum (St John’s Wort) dried extracts are the most 
common and are recommended and applied for the treatment of  mild to 
moderate depression (DGPPN et al., 2015; Ernst, 2007; Concerto et al., 2017). 
Clinical meta-analysis demonstrated a similar effectiveness of Hypericum 
perforatum preparations compared to standard antidepressants, however with a 
much better adverse effect profile (Whiskey et al., 2001; Ernst, 2007; Sarris, 
2011). 
1.2 Depression and stress 
Although the underlying pathology of depression remains to be completely 
understood, it is generally accepted that chronic stress and stressful life events 
(especially in early childhood) strongly predispose an individual to develop a 
clinical depression (Faria et al., 2014; Charney & Manji, 2004; Hindmarch, 2001; 
Massart et al., 2012; Duman et al., 2016; Magalhães et al., 2017). Chronic stress 
leads to a hyperactivation of the sympathetic nervous system and the 
hypothalamic-pituitary-adrenal (HPA) axis, resulting in increased circulation of 
catecholamines and glucocorticoids (e.g. cortisol) (Chrousos, 2009; Gunnar & 
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Quevedo, 2007). The HPA axis mediates and regulates prolonged stress 
response (Weisbuch et al., 2009) providing metabolic support by mobilizing 
glucose from energy stores by glycogen degradation  (Rabasa & Dickson, 2016) 
and suppressing growth, maturation and the immune response (van Bodegom et 
al., 2017; Kyrou & Tsigos, 2007). Glucocorticoids induce stress adaption mainly 
by interaction with glucocorticoid receptors, which modulate gene expression 
(Dindia et al., 2012; De Kloet et al., 2005; Tsigos & Chrousos, 2002; van 
Bodegom et al., 2017). In contrast to catecholamines, which do not easily cross 
the blood-brain barrier (BBB), the brain represents the major target organ for 
glucocorticoids (Gunnar & Quevedo, 2007). Extreme or chronic stress exposure 
and subsequent continuous upregulation of glucocorticoids eventually induce 
adaptive changes which have health-damaging long-term consequences 
contributing to the psychopathology of multiple stress-related mental illnesses 
like depression and posttraumatic stress disorder (PTSD) (Davis et al., 2017; 
Duman et al., 2016; Magalhães et al., 2017; Kyrou & Tsigos, 2007; van Bodegom 
et al., 2017). Especially in the hippocampus chronically upregulated cortisol 
mediate deleterious changes in neuroplasticity, eventually leading to functionally 
disrupted negative-feedback mechanisms, which result in hyperactivity of the 
HPA axis (Frodl & O`Keane, 2013; Lee et al., 2010; Andrade & Rao, 2010). 
 
1.3 Stress and membrane fluidity 
Hypercortisolemia has been described to disturb monoaminergic systems in a 
manner similar as observed in depression (De Kloet et al., 2005; Tafet & 
Bernardini, 2003). This include among others a down regulation of ß-adrenergic 
receptors (Fernstrom, 1994; Jakobs et al., 2013) and the serotonin 1A receptor 
(Fernandes et al., 2017; Charney & Manji, 2004). Beside changes in receptor 
density, changes in receptor activity have been described as well. These include 
for example an augmentation in serotonin 1A receptor signaling (Joca et al., 2007; 
Fernstrom, 1994). 
On the other side, chronic glucocorticoid exposure has also been demonstrated 
to modulate membrane properties. In this context a changed membrane fluidity 
has been examined by several chronic approaches applying cortisol and 
chemically similar glucocorticoids including hydrocorticosterone and 
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dexamethasone in human lymphocytes (Tolentino et al., 1991), HeLa cells 
(Johnston & Melnykovych, 1980), rat liver, and intestinal membranes (Kapitulnik 
et al., 1986; Neu et al., 1986; Brasitus et al., 1987).  
Membrane fluidity refers to the molecular disorder and motion within the 
membrane bilayer (Los & Murata, 2004). A change in membrane fluidity has a 
modulatory impact on the lateral mobility and activity of membrane-bound 
receptors (Los & Murata, 2004; Fajardo et al., 2011; Ohvo-Rekilä et al. 2002). A 
direct cortisol induced alteration in membrane fluidity has for example been 
correlated to altered synaptosomal plasma membrane-associated Na+, K+-
ATPase activity (Deliconstantinos, 1985). Such a direct cortisol-induced change 
in membrane fluidity may affect signaling pathways as shown for protein kinase-
mediated phosphorylation, which modulates the activity status of membrane 
associated receptors (Dindia et al, 2012).  
The lipid composition of membranes substantially influences physiochemical 
properties like membrane fluidity. In general, the cholesterol content, 
phospholipid composition and length and saturation degree of attached fatty 
acids represent modulators of the membrane fluidity (Fajardo et al., 2011).  
Remarkably, chronic unpredictable stress has been identified to alter 
phospholipid profiles in the brain of depressed mice with increasing 
phosphatidylcholine (PC) and phosphatidylethanolamine (PE) levels and 
decreasing phosphatidylinositol (PI) level (Faria et al, 2014). A very similar 
chronic unpredicted stress protocol in rats examined rather brain-area specific 
changes with a significant increase in hippocampal PI and a decrease in PE in 
the prefrontal cortex of rats (Oliveria et al., 2016). Increased PC levels were also 
found in postmortem prefrontal cortex samples of bipolar disorder patients 
(Schwarz et al, 2008) as well as abnormalities in PI turnover with depression and 
bipolar disorders (Farooqui et al., 2000).  
Epidemiological studies also revealed a reduced level of polyunsaturated 
omega-3 fatty acids (docosahexaenoic acid (DHA) and eicosapentaenoic acid 
(EPA)) in depressed patients (Peet & Stokes, 2005; Logan, 2003; Fernandes et 
al., 2017). DHA and to a lesser extend EPA are especially enriched in brain 
synaptic membranes and have a high impact on membrane fluidity and 
functional activity of membrane proteins (Kidd, 2004; Kidd, 2007; Weiser et al., 
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2016; Dyall, 2015). And in fact EPA and DHA have been described to modulate 
ion channels (Mischoulon & Rosenbaum, 2008; Kidd, 2004), inhibit the protein 
kinase C (PKC) signal transduction enzyme complex (Kidd, 2004) and even 
modulate neurotransmitter signaling. For example EPA blocks the 
prostaglandin-mediated inhibition of serotonin release from presynaptic 
membranes, and DHA improves membrane embedded serotonin receptor 
accessibility (Patrick & Ames, 2015). Interestingly, DHA and EPA seem to 
inverse correlate with HPA axis activity in depressed patients (Fernandes et al., 
2017). 
In addition multiple investigations described a correlation between acute and 
chronic elevated glucocorticosteroid levels and increase in cholesterol content 
(Floyd et al., 2007; Filburn 2000; Yehuda et al., 2000), the precursor of steroid 
hormones like cortisol (Yehuda et al., 2000). On the other side a low 
concentration of cholesterol and high concentration of cortisol, was described in 
major depressed patients (Jow et al., 2006; Papakostas et al., 2004) and in 
suicide behavior (Marcinko et al., 2005). This depletion in cholesterol probably 
results from HPA axis hyperactivity and the correlating high demand in cortisol 
synthesis. 
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1.4  Aim and approach 
Chronic stress represents a key factor for predisposing an individual to develop 
a clinical depression. Besides changes in receptor expression, cortisol seems to 
modulate membrane-associated signaling by alterations in membrane properties 
like fluidity.  
The present work investigates the possible influence of antidepressant 
medication with Hypericum perforatum dried extract Ze117 compared to synthetic 
antidepressants and stress hormones on the plasma membrane fluidity in C6 
cells. As the antidepressant effect of Hypericum perforatum extracts originate 
from various bioactive ingredients, single constituents were also tested for a 
contributing effect on membrane fluidity. 
In order to proper distinguish between an adaptive and a direct membrane 
interacting effect on membrane fluidity, C6 cells were incubated for an acute (1h) 
and a chronic (6-8 days) period of time. Membrane fluidity was assessed by 
fluorescence anisotropy measurements applying DPH (1,6-diphenyl-1,3,5-
hexatriene) and TMA-DPH (1-(4-(trimethylamino)phenyl)-6-phenylhexa-1,3,5-
triene), which probe the dynamic behavior of the surrounding lipid 
microenvironment within different depths of the plasma membrane. Adaptive 
changes in membrane fluidity are further correlated to lipidomic changes. PC and 
PE represent the most prominent phospholipids within biological membranes, 
showing opposite effects on membrane fluidity. An increase in PC/PE ratio 
correlates with an enhanced membrane fluidity. Approaching thin layer 
chromatography (TLC) alterations in the PC/PE ratio within whole cell lipid 
extracts was examined and further investigated for underlying changes in PC 
biosynthesis. Incubation with deuterated choline (choline-D9), the starting 
compound of the PC de-novo biosynthesis pathway, and subsequent detection 
by mass analysis hereby allows identification of PC-species specific changes in 
time-dependent choline-D9 incorporation. Finally PC-species under investigation 
were characterized by their fatty acid moieties.  
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2 Materials and Methods 
2.1  Materials 
2.1.1  Chemicals and reagents 
Desipramine hydrochloride, citalopram hydrobromide, dobutamine 
hydrochloride, quercetin, rutin hydrate, DPH (1,6-diphenyl-1,3,5-hexatriene), 
TMA-DPH (1-(4-(trimethylamino)phenyl)-6-phenylhexa-1,3,5-triene), choline 
chloride, choline chloride-trimethyl-d9 (choline-D9),  methyl-β-cyclodextrin 
(MβCD), L-α-phosphatidylcholine, L-α-phosphatidylethanolamine  and cortisol 
were purchased from Sigma (Taufkirchen, Germany).  
The Hypericum perforatum extract Ze117 (batch-no. V803900) was supplied by 
Max Zeller Söhne AG (Romanshorn; Switzerland). 
Amentoflavone, biapigenin, hyperforin and hypericin were supplied by HWI 
pharma services GmbH (Rülzheim, Germany). All reagents for cell culture were 
from Gibco by Thermo Fisher Scientific (Bremen, Germany).  
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2.2  Methods 
2.2.1 High performance liquid chromatography 
High performance  liquid chromatography was performed applying the Agilent 
1200 HPLC system (Agilent Technologies, Wilmington, DE, USA) equipped with 
a degasser (G1322A), a quaternary pump (G1311A), an autosampler (G1329A) 
and a photodiode array detector (G1315D). The analytical column employed was 
a reversed-phase Symmetry TM C18 HPLC-column of 150 mm × 3.9 mm and 
5 μm particle size (Waters Corporation, Milford, Massachusette, USA). The 
Hypericum perforatum dried extract Ze117 dissolved in 50% ethanol (EtOH) and 
ingredient standards dissolved in methanol (MeOH) were injected to the HPLC 
system programmed as described in Table 2.2.1. Detection was performed at 
254 nm and 590 nm. Chromatograms were registered and evaluated using 
Agilent Chemstation Software version B.04.01. Identification of ingredients was 
carried out by comparison of UV spectra and retention times to reference 
substances. 
 
Table 2.2.1:  HPLC linear gradient program and mobile phase composition 
time in min 
mobile phase A 
acetonitrile/ H2O/ 
85% phosphoric acid 
(19:80:1 v/v/v) 
mobile phase B 
acetonitrile/ MeOH/ 
85% phosphoric acid 
(59:40:1 v/v/v) 
flow rate 
(ml/min) 
0 100 % 0 % 0.5 
8 100 % 0 % 0.5 
15 92.5 % 7.5 % 0.5 
37 50 % 50 % 0.5 
52 0 % 100 % 0.5 
52.01 0 % 100 % 1 
85 0 % 100 % 1 
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2.2.2  Cell culture  
2.2.2.1 General cell culture  
Rat glioblastoma (C6) cells obtained from the DSMZ (Leibniz Institute DSMZ-
German Collection of Microorganisms and Cell Cultures GmbH, Braunschweig, 
Germany) were generally cultured in Dulbecco`s modified Eagle medium 
(DMEM/F-12), supplemented with 5 % fetal bovine serum (FBS), 2 mM L-
glutamine, 100 units/ml  penicillin and 100 µg/ml streptomycin. C6 cells were 
cultured in 10 cm culture dishes containing 10 ml culture medium at 37 °C in a 
humid atmosphere containing 5% CO2. All steps of cell cultivation and processing 
were performed under sterile conditions using only prewarmed (37 °C) 
solutions/media and trypsinization solutions.  
Cell passaging into the next generation was performed as soon as cell confluency 
reached 80-95 %. For this procedure the “spend” medium was sucked away and 
attached C6 cells were trypsinized with 3 ml trypsin/EDTA® solution. Incubation 
was performed at 37 °C, 5 % CO2 until cells detached. Trypsin was inactivated 
by adding 10 ml of culture medium and rinsing the culture dish at least twice. The 
cell suspension was transferred into a 15 ml Falcon tube. Centrifugation at 
1300 x g for 3 min at room temperature (RT) was performed and the supernatant 
was sucked away. The gained cell pellet was resuspended in 1 ml culture 
medium and cell seeding into the next generation was performed using an 
appropriate splitting ratio, usually 1:20. Cells are seeded into a new Petri dish 
containing fresh 10 ml cell culture medium. Using a splitting ratio of 1:20 results 
in the next generation of C6 cells to become confluent again after 4 days. The 
new generation is marked on the top of the Petri dish with an increasing passage 
number (PN = n + 1). Incubation at 37 °C and 5 % CO2 followed until cells again 
become confluent. C6 cells with a passage number (PN) of max. 30 were used 
for cell culturing and experimental processing. Parallel to the general cell culture, 
the splitting procedure was also used to seed C6 cells in preparation to 
experimental approaches.  
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2.2.2.2 Cell culture under chronic incubation 
Chronic incubation of C6 cells was performed for at least 6 days using cell culture 
medium enriched with defined concentrations of test substances under 
investigation (Table 2.2.2.2). To each series of chronic experiments a 
corresponding untreated control was prepared. Solvents were individually added 
to each condition and to the untreated control, to reach a uniform solvent 
concentration of max. 0.15% MeOH and 0.25% EtOH.  
An initial splitting ratio of 1:20 causes C6 cells to become confluent again on the 
4th day of chronic incubation. Since 0.025-0.05 mg/ml of Ze117 and 1 µM cortisol 
showed an inhibitory effect on cell proliferation, cell cultures under these 
conditions have been directly seeded in higher cell numbers using an initial 
splicing ratio of 1:15 for 0.05 mg/ml Ze117 and 1:17  for 0.025 mg/ml Ze117 and 
1 µM cortisol.  
Table 2.2.2.2: List of test substances and applied concentrations within  
chronic investigation  
category substance stock solutions: assay 
concentrations,  
chronic approach 
stress hormons terbutaline 1 mM in H2O 1, 0.1 µM 
dobutamine 1 mM in MeOH 1, 0.1 µM 
cortisol 1 mM in MeOH 1, 0.1, 0.01 µM 
antidepressants DMI 1 mM in 50%  EtOH 1 µM 
citalopram 1 mM in 50%  EtOH 1 µM 
Hypericum 
perforatum 
extract 
and bioactive 
ingredients  
Ze117 10 mg/ml  in 
50%EtOH 
0.05,  0.025, 0.01 mg/ml 
hypericin 0.1 mM MeOH 0.1, 0.01, 0.001 µM 
hyperforin 1 mM in MeOH 1, 0.1, 0.01 µM 
quercetin 1 mM in MeOH 1.5, 1, 0.5 µM 
rutin 2 mM in MeOH 1 µM 
biapigenin 1 mM in MeOH 1.5, 1, 0.5 µM 
amentoflavone 1 mM in MeOH 1.5, 1, 0.5 µM 
control 
substance 
choline 1 M in H2O 10 mM 
 
At the 4th day of incubation C6 cells are split again and either seeded to grow on 
glass cover slips in preparation to fluorescence anisotropy measurements (see 
section 2.2.3.1) or are again transferred into new Petri dishes filled with 10 ml of 
the corresponding incubation medium. Seeding into new Petri dishes was 
performed using the splitting ratio 1:10. However, the splitting ratio was also 
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adjusted to 1:7 for 1 µM cortisol and 0.025 mg/ml Ze117 or 1:5 for 0.05 mg/ml 
Ze117 in order for all conditions to reach uniform confluent cells on the 6th day.   
Optionally, at the 5th day C6 cell were exposed for the last 24 h of incubation to 
50 µM choline-D9 in preparation to the pulse-chase approach (see section 
2.2.4.3.1). 
At the 6th day of chronic incubation, the medium was sucked away and the cell 
culture dishes were placed on ice under non sterile conditions. 2 ml of ice cold 
water was added and C6 monolayer were harvested by cell scraping. The gained 
cell suspension was transferred to a 15 ml Falcon tube placed on ice. 
Centrifugation for 3 min at 1300 x g followed. The supernatant was sucked away 
and the cell pellet within the 15 ml Falcon tube was immediately placed back on 
ice for further lipid analysis or stored at -20°C.  
The described chronic treatment procedures and all including variations in 
preparation to experimental membrane fluidity and lipid analysis is also presented 
in Figure 2.2.2.2.  
 
Figure 2.2.2.2: Experimental variations within cell culturing under chronic 
incubation in preparation to fluorescence anisotropy, TLC and ESI-MS 
approached in this work. C6 cells under chronic incubation were split at day 4 and 
seeded to grow on glass cover slips in 12-well plates in preparation to fluorescence 
anisotropy measurements at day 6-8. In preparation to lipid analysis via TLC and ESI-
MS, C6 cells were seeded into new Petri dishes and were harvested at day 6 by cell 
scraping on ice, followed by lipid extraction. For the pulse-chase experiment applying 
ESI-MS analysis C6 cells were additionally exposed to 50 µM choline-D9 for the last 24 
h of chronic incubation (6 days).   
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2.2.3 Membrane fluidity by fluorescence anisotropy 
measurements 
2.2.3.1 C6 cells seeded on glass cover slips  
 
In preparation to fluorescence anisotropy measurements, C6 cells were seeded 
in 12-well plates to grow on 13.5 x 13.5 mm glass cover slips, custom-build to 
exactly fit the inner diagonal plane of the cuvette.  
C6 cells under chronic treatment conditions usually at the 4th day, or C6 cells 
under regular cell culture conditions for acute measurements were trypsinized by 
the usual procedure. In order for all cell samples to reach an appropriate and 
uniform confluency at the experimental day, individual cell concentration from 
each cell suspension was determined. The cell pellet resuspended in 1 ml cell 
culture medium was further diluted 1:10 and applied to a Neubauer counting 
chamber.  The counting chamber was placed under a microscope and the cell 
concentration was determined according to Figure 2.2.3.1. 
 
 
 
Figure 2.2.3.1: Cell concentration determination via Neubauer counting chamber. 
(A) One side (or both) of the Neubauer counting chamber is filled with the cell suspension 
of unknown cell concentration. A defined volume is sucked into the space between 
counting chamber and cover glass. (B) The microscopic view allows the visualization of 
4 big squares, each containing 4 x 4 smaller squares (C), which is counted for the number 
of residing cells. The green arrow describes the direction of counting including all cells 
left and on the bottom, while excluding all cells bordering on the top and right to the large 
square. Finally the cell concentration is calculated using the following formula:  
 
                       
𝑐𝑒𝑙𝑙𝑠
𝑚𝑙
=
n (counted cells) 𝑥 10.000
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑠𝑞𝑢𝑎𝑟𝑒𝑠 𝑥 𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟
                  (equation 1) 
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The determined cell concentration allowed the uniform seeding of C6 cells into 
12-well plates, with each well filled with a 13.5 x 13.5 mm glass cover slip and 
1 ml of the corresponding incubation media. It is to be noted, that cells under 
chronic incubation with 0.025-0.05 mg/ml Ze117 were for reasons of better cell 
adherence seeded on poly-D-lysine (PDL) coated glass cover slips (see the 
following section). In general 70 000 cells/well were seeded for additional 2 days 
of incubation. For additional 3 and 4 days of incubation 30 000 and 10 000 
cells/well were seeded, respectively. Cells under chronic incubation with higher 
concentrations of cortisol or Ze117 were seeded using cell numbers increased 
by 15% for 1 µM cortisol and 0.025 mg/ml Ze117 and 30% for 0.05 mg/ml Ze117. 
 
2.2.3.2 PDL-coating of glass cover slips  
For chronic incubation with Ze117 concentrations of 0.025 mg/ml and 0.05 mg/ml 
and their corresponding controls, C6 cells were seeded on poly-D-lysine (PDL) 
coated glass cover slips in 12-well plates. A stock solution of 100 x PDL (10 mg/ml 
in PBS) was diluted 1:100 to reach a final concentration of 1 x PDL. One ml of 
this solution was transferred to each well and incubated either for at least 1 h at 
37°C or overnight at 4°C. Afterwards, each well was washed with PBS and the 
empty 12-well plates were dried for about 30 min at 37°C, ready for cell seeding 
as described above/in the previous section. 
 
2.2.3.3 Acute exposure of adherent C6 cells before fluorescence 
anisotropy measurements 
Fluorescence anisotropy measurements after acute exposure of C6 cells to 
substances under chronic investigation were performed in addition. For this 
purpose C6 cells under general cell culture conditions grown on glass cover slips 
were just prior to the measurement procedure transferred to a new 12-well plate 
and incubated for 1 h in 1 ml of the corresponding incubation medium. In detail 
those incubation media contained either 1 µM cortisol, terbutaline, dobutamine, 
DMI, citalopram, hyperforin, rutin or 1.5 µM quercetin, amentoflavone, biapigenin 
or 0.05 mg/ml Ze117. Afterwards the cover slip was washed 3 times in Hank´s 
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balanced salt solution without phenol red (HBSS - phenol red), ready for 
background (Bkg) determination for the fluorescence anisotropy measurement 
procedure (see section 2.2.3.5). 
 
2.2.3.4 Cholesterol depletion in adherent C6 cells before 
fluorescence anisotropy measurement 
Cholesterol depletion was performed by transfer and incubation of the cell 
monolayer grown on glass cover slips into a new well, filled with 1 ml 10 mM 
methyl-β-cyclodextrin (MβCD) in serum-free cell culture medium for 30 min at 
37°C. The corresponding control cell monolayer of identical seeding procedure 
and confluency was in parallel also incubated with serum-free culture medium 
(without MβCD). Afterwards the cover slips were washed once in serum-free cell 
culture medium followed by washing 3 times in HBSS (- phenol red), ready for 
background (Bkg) determination for the fluorescence anisotropy measurement 
procedure (see section fluorescence anisotropy measurement). 
 
2.2.3.5 Fluorescence anisotropy measurements on adherent 
cells grown on glass cover slips 
Steady-state fluorescence anisotropy measurements (L-configuration) were 
performed using the LS 55 fluorescence spectrometer (Perkin-Elmer, Rodgau, 
Germany) equipped with a circulation thermostat connected to the cell sample 
holder allowing constant 37°C during measurements. The sample holder was 
rotated to adjust the cell monolayer within the cuvette to a 30° angle relative to 
the incident light beam, if not otherwise stated. Within the sample holder a 7 mm 
plastic piece was inserted, resulting in a higher stand of the cuvette and the light 
beam to toughly pass through the monolayer. The emission polarizer was set 
vertical and the absorption polarizer was set vertical or horizontal to allow 
intensity measurements of polarized light signals parallel (II) by vertical and 
vertical (vv) and perpendicular (⊥) by vertical and horizontal (vh) settings (Figure 
2.2.3.5). For DPH and TMA-DPH these intensities were determined at ʎex: 360 
nm (slit 5 nm) and ʎem: 430 nm (slit 10 nm). 
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Figure 2.2.3.5: Principle of fluorescence anisotropy experimental setup. A light 
beam was polarized by a polarizer before reaching the cell monolayer (grown on glass 
cover slip) with an incident angle of 30°, if not other stated. This results in polarized 
emission of the excided-state fluorophores (DPH and TMA-DPH) along a preferential 
axis. With increasing rotational mobility during the absorption transition moment the 
emitted light was stronger distributed within different polarization planes (Intensity II and 
) resulting in a decreased anisotropy value. 
 
 
 
Each monolayer grown on glass cover  slips was prior to the labeling procedure 
washed  3 times with HBSS (- phenol red) and placed into a cuvette filled with 2 
ml HBSS (- phenol red) and the individual cell background (Bkg) intensities 
parallel and perpendicular to the initial polarization  were  determined.  
Labeling was performed by incubation of the cell monolayer with 90 µM DPH or 
30 µM TMA-DPH in HBSS (- phenol red) for 30 min at 37°C. Afterwards cover 
slips were washed 3 times with HBSS (- phenol red) and placed again into the 
cuvette containing 2 ml of HBSS (- phenol red).  
 
Table 2.2.3.5: Stock and working concentration of DPH and TMA-DPH. 
 stock solution labeling concentration 
TMA-DPH 5 mM in EtOH 30 µM 
DPH 10 mM  in DMSO 90 µM 
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Within the following 30 min up to 7 individual fluorescence anisotropy 
measurements were performed, measuring intensities vv and vh. The measured 
intensities were corrected by subtracting the Bkg signals vv and vh from the 
measured intensity vv and vh and fluorescence anisotropy (r) was calculated 
using the formula below (Chen et al., 1999); 
 
Anisotropy r =   
I vv  − Gf ∙ I vh
I vv + 2 ∙ Gf ∙ I vh
   (equation 2)    
 
 
I vv=measured I vv – Bkg vv   
I vh= measured Ivh – Bkg vh 
 
   Gf= 
𝐼 ℎ𝑣
𝐼 ℎℎ
    (equation 3) 
  
The grating factor (Gf) is determined previously to the anisotropy measurement 
and represents the correcting factor to compensate for the polarization bias of 
the instrumental polarization. Own measurements revealed a Gf of 1 and 
therefore it was neglected. 
Each condition is measured in duplicates (2 samples of identical incubation 
condition) and finally normalized to the mean of the control (see section 2.2.5).  
 
2.2.4 Phospholipid analysis  
2.2.4.1 Lipid extraction  
Falcon tubes containing cell pellets, harvested after chronic incubation, were 
placed on ice. The cell pellets were resolved in 0.5 ml ice cold distilled water and 
lysed by being forced at least 30 times through a 20 G cannula using a syringe. 
The whole cell homogenate was transferred into a small glass tube filled with 3 ml 
of a CHCl3/MeOH solution (2:1, v/v) and a small stirring bar. The glass tubes were 
hermetical closed, proper vortexed and placed into a water bath at 60 °C and 
magnetic stirring for 4 h. Afterwards 1 ml of MeOH were added, receiving a 
CHCl3/MeOH ratio of 1:1 (v/v). The tubes were again proper closed, vortexed and 
placed for additional 3.5 h under magnetic stirring in the 60 °C heated water bath.  
Finally, the solution was filtered through a glass wool plugged Pasteur pipette to 
separate the solution from precipitated proteins/non-lipid contaminants.  
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The collected lipid solution was concentrated by placing the open glass tubes into 
a 50 °C heated water bath under a gentle N2-stream. 
After ~ 1.5 h the solvent has completely removed and the dried lipid fraction was 
subsequently resolved in 200 µl CHCl3/MeOH (1:1, v/v) for TLC analysis (see 
section below) or 100 µl of a isopropanol/hexane/100 mM ammonium formate 
mixture (50:40:10, v/v/v) or a CHCl3/MeOH mixture (1:2, v/v) containing 5 mM 
ammonium acetate or ammonium chloride. 
 
2.2.4.2 High performance thin layer chromatography of lipid 
extracts. 
High performance thin layer chromatography (HPTLC) silica gel plates 
(20 x 10 x 0.2 cm) were just prior to experimental performance removed from the 
manufacturer´s storage box and conditioned for 5 min at 180°C. Each plate was 
loaded with a PE (0.25-1.5 µg) and PC (0.5-3 µg) standard, test samples and 
corresponding controls, all dissolved in CHCl3/MeOH (1:1, v/v). Samples were 
spotted manually as 5 mm bands on HPTLC plates, keeping a spacing of 10 mm 
between samples and 15 mm margin from the bottom and the side edges of the 
plate.  
TLC developing chamber (22 x 22 x 10.5 cm) was prepared, containing 94 ml 
freshly prepared mobile phase CHCl3/MeOH/H2O (65:25:4 (v/v/v)) and 
chromatography filter paper.  
The TLC developing chamber was closed and allowed to saturate for about 1 h, 
until the solvent has run the entire height of the chromatography filter paper.  
Afterwards up to 3 loaded HPTLC plates were placed into the camber. The 
camber was kept close again and within approximately 20 min HPTLC plates 
were socked with the mobile phase up to about 1 cm below the top. The plates 
were removed from the TLC chamber and air-dried, followed by being shortly 
immerged into a TLC detection immersion bath containing 10% copper (II) sulfate 
as detection reagent. HPTLC plates were dried using an air-blower until plates 
appear in a uniform light blue staining. The dried TLC plates were developed at 
180°C for about 5-10 min until proper visualization of PE and PC bands.  
Digital images of the developed TLC plates were generated and densitometrically 
analyzed using the Aida Image Analyzer software version 450 (Raytest, 
                                                                                                                                 Materials and Methods 
 
17 
 
Straubenhardt, Germany) under the inverted quantum level parameter. For each 
plate the detection area of densitometric determination was preset to an adjusted 
shape and size for PE and PC, respectively, enabling to fit these bands 
individually. This preset detection region was also applied to determine the 
corresponding background (Bkg) next to individual PE and PC bands. From each 
determined lipid signal the corresponding Bkg was subtracted, leaving the pure 
lipid signal. The resulting calibration curves (plotting µg vs. signal intensity) were 
applied for PE and PC quantification if an accuracy of R2 ≥ 0.96 was reached. 
The calculated µg-values of the PC and PE fractions from each sample were set 
into ratio (PC/PE) and are presented as relative change compared to the control 
PC/PE ratio. 
 
2.2.4.3 Pulse-chase of phosphatidylcholine de-novo synthesis 
2.2.4.3.1 Pulsing chronic incubated C6 cells with choline-D9 in 
preparation to ESI-MS 
 
C6 cells under general cell culture conditions or C6 cells at the 5th day of chronic 
treatment conditions (see section 2.2.2.2) were 24 h before cell harvesting 
exposed to 50 µM choline-D9 (Figure 2.2.4.3).  
For this purpose the spend medium was sucked away and 10 ml of new 
incubation medium of individual incubation conditions enriched with 50 µM 
choline-D9 was carefully added. After 24 h of incubation all reactions were 
stopped by harvesting C6 cells by scraping on ice. Lipids were extracted and 
dissolved in 100 µl isopropanol/hexane/100 mM ammonium formate mixture 
(50:40:10, v/v/v) as described previously (see section 2.2.4.1). The gained lipid 
extract was further diluted 1:20, ready for direct infusion ESI-MS analysis of 
choline-D9 incorporation into PC, as described below.  
 
Figure 2.2.4.3.1: Chemical structure of choline-D9. The abbreviation D describes 
deuterium, the stable 2H isotope (heavy hydrogen). 
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2.2.4.3.2 Chasing choline-D9 incorporation into PC via mass 
spectrometry 
Detection of choline-D9 incorporation into individual PC species was performed 
on a HCT Ultra ion trap mass spectrometer (Bruker Daltonics, Bremen, Germany) 
equipped with an ESI ion source. The samples were loaded into a clean 250 µl 
Hamilton syringe and injected to the instrument with a continuous flow of 5 µl/min 
using the KDS 100 legacy syringe pump (KD Scientific, Boston, MA, USA). 
Parameters of the MS instrument were as follows: positive mode, nebulizer 
pressure 16 psi; dry gas flow 7 l/min; dry gas temperature 300 °C; mass range 
100-1000 m/z; scan speed 8.100 m/z per second. MS scans were recorded for 1 
min. The gained sum MS spectra were analyzed using the DataAnalysis (Bruker 
Daltonics) software. 
PC species and their deuterated derivatives were detected, exposing a mass-to-
charge (m/z) difference of 9. Their identities as PC lipids were undoubtedly 
proven  
by +MS2 mediated neutral loss of the head group (phosphocholine -183 m/z or 
phosphocholine-D9 -192 m/z) and the loss of trimethylamine (-59 m/z) or 
trimethylamine-D9 (-68 m/z) from the parent ion (Figure 2.2.4.3.2).  
 
 
 
 
                                      PC m/z  =  X                                                    PCD9  m/z  =  X + 9  
Figure 2.2.4.3.2: Identification principle of PC-pairs by positive mode mass analysis. 
Natural occurring PC species (A) and their deuterated derivatives (B) result from choline and 
choline-D9 incorporation via the de-novo biosynthesis pathway, respectively. The detectable 
mass shift of + 9 m/z results from the 3 deuterated methyl groups of choline-D9 incorporated into 
PC. The identities of PC lipids were proven within +MS2 by forming identical DAG-like products 
by the loss of phosphocholine (with m/z = 183) or phosphocholine-D9 (with m/z = 192). The loss 
of trimethylamine (with m/z =  59) or trimethylamine-D9 (with m/z = 68) from the parent ion is also 
examined. 
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For each sample, signal intensities of the most prominent PC species and their 
deuterated derivatives, were determined. Finally, the percentage amount of 
choline-D9 incorporation into each PC-species under investigation was 
calculated, applying the formula below; 
 
 
Species dependent choline-D9 
incorporation in % 
 
= 
I PCD9  x 100 
  (equation 4) I PCD9  + I PC   
I PC     = Signal intensity of natural occurring PC species 
I PC D9 = Signal intensity of corresponding deuterated PC species 
 
2.2.4.3.3 PC species identification via negative mode MS3 
PC species of interest were further characterized by their fatty acid moiety 
combination via negative mode fragmentation. For this purpose lipid extracts 
(derived from C6 cells not exposed to choline-D9) were dissolved in 100 µl of a 
CHCl3/MeOH mixture (1:2, v/v) supplemented with 5 mM ammonium acetate or 
ammonium chloride, allowing negative mode observation of anionic PC adducts. 
Just prior to the measurement samples were further diluted 1:100 and analyzed 
for reasons of higher resolution with the TriVersa Nanomate chip-based 
electrospray device (Advion Biosciences, Ithaca, USA) coupled to the ultrahigh 
resolution LTQ Orbitrap Velos mass spectrometer (Thermo Fisher Scientific, 
Bremen, Germany). The instrument was controlled for data collection by the 
Xcalibur software version 2.2 (Thermo Fisher Scientific). Ionization voltage and 
gas (nitrogen) pressure were set to 1.6 kV and 0.3 psi, respectively.   Within the 
negative full scan modus PC species were detected as [M+CH3COO]- or [M+Cl]-  
adducts over a mass range of m/z = 700-900. Each PC species was isolated 
within an individual small m/z range window, followed by MS2 fragmentation in 
the ion trap under collision induced dissociation (CID) set to 35-40%. The gained 
[M-CH3]- fragment was further isolated and fragmented leaving the final fatty acid 
products (Figure 2.2.4.3.3). The identity of the examined fatty acid products was 
determined by comparison to online data base 
(http://www.byrdwell.com/PhosphatidylCholine/FattyAcids.htm).  
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Figure 2.2.4.3.3: Identification principle of PC fatty acid moieties by negative mode 
mass analysis. PC is detected within the negative mode as anionic chloride [M+Cl]- or 
acetate [M+CH3COO]- adduct. PC adduct was fragmented by –MS2 resulting in a [M-
CH3]–  product. Following fragmentation of this [M-CH3]-  product by –MS3 leaves free 
fatty acid products. The sn-2 fatty acid product [R2COO]- is distinguished from the sn-1 
fatty acid product [R1COO]-  due to it appears with a higher abundancy within the -MS3 
spectrum. 
 
2.2.5 Result processing and statistics  
 
Raw data were processed by Excel (Microsoft office 2013, Redmond, WA, USA). 
Results of fluorescence anisotropy measurements and PC/PE ratio assessments 
via TLC are presented as relative change compared to the control. Normalization 
was achieved by setting the mean value of the controls (MVc) from each 
independent experiment to 1. All associated measured values of control and test 
substances were set into relation to this MVc. Results of at least 3 independent 
experiments were pooled, with the exception of obvious outliner, and presented 
as mean  and the standard error of the mean (SEM).  
Outliner are defined for fluorescence anisotropy experiments by a deviation of 
≥ 0.10 and ≥ 0.15 from the individual mean of each group for chronic and acute 
measurements, respectively.  
Within TLC experiments for PC/PE ratio assessment only results generated by a 
calibration curve fitting linear range accuracy of R2 ≥ 0.96 were pooled. 
Diagrams are generated using Prism V.6 software (GraphPad, La Jolla, CA, 
USA). 
For statistical analysis the unpaired t-test was performed using the Prism V.6 
software (GraphPad). Results significantly different from their corresponding 
control groups are marked by * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001.  
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3 Results 
3.1 HPLC analysis of Ze117 
The applied Hypericum perforatum dried extract Ze117 was characterized for the 
presence of relevant ingredients applying HPLC analysis.  As presented in Figure 
3.1 the applied Ze117 extract was identified to be rich in flavonoids including rutin, 
hyperoside, quercitrin, isoquercetin, quercetin, biapigenin, the phloroglucinol 
hyperforin, and the naphthodianthrones hypericin and pseudohypericin. 
Amentoflavone represents a minor constituent. Rutin, quercetin, biapigenin, 
amentoflavone, hyperforin and hypericin are presented in addition with chemical 
structure as these substances become relevant within following fluorescence 
anisotropy measurements. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1: HPLC chromatogram of Ze117. 
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3.2 Fluorescence anisotropy 
3.2.1 Evaluation of fluorescence anisotropy measurements 
Within this study, changes of the plasma membrane fluidity of C6 cells were 
assessed by fluorescence anisotropy measurements. For this purpose DPH (1,6-
diphenyl-1,3,5-hexatriene) and TMA-DPH (1-(4-(trimethylamino)phenyl)-6-
phenylhexa-1,3,5-triene) were applied probing different plasma membrane 
depths.  
Fluorescence anisotropy measurements, usually performed in cell suspensions, 
were performed on adherent C6 cell monolayers grown on glass cover slips 
keeping cells in their naturally adherent form. In comparison to the regular 
described light angle of 45° relative to the cell monolayer (referred to as the 
“magic angle”) measurements performed at an incident light angle of 30° 
effectively minimized the background signal (Bkg) and led to more stable and 
reliable anisotropy measurements, as presented for TMA-DPH (Figure 3.2.1-1). 
 
 
Figure 3.2.1-1: Changes in fluorescence anisotropy (r) and corresponding 
intensity values over time measured by TMA-DPH (30 µM, 30 min) in adherent C6 
cells exposed to an incident light angle of 30° or 45° relative to the cell monolayer. 
(Upper panel) Anisotropy values are presented as the measured and the corrected 
anisotropy values (determined by Bkg subtraction). (Lower panel) The corresponding 
intensities measured at vertical/vertical (vv) and vertical/horizontal (vh) polarization 
settings are presented as measured and corrected values (after Bkg subtraction). 
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Within this experimental setup applying an incident light angle of 30° a labeling 
concentration of 30 µM TMA-DPH and 90 µM DPH incubated for 30 min at 37 °C 
was found to reach suitable intensities (after Bkg subtraction) for reliable 
anisotropy calculation. The low quantum of DPH compared to TMA-DPH, makes 
DPH more susceptible to signal fluctuations and Bkg noise interferences. This 
problematic situation could however be compensated by applying a 3-fold 
increased DPH concentration compared to TMA-DPH. 
A typical DPH and TMA-DPH fluorescence anisotropy and intensity profile is 
presented in Figure 3.2.1-2.  Although signal intensities showed to increase for 
DPH while TMA-DPH signal intensities decrease with passing time, a stable 
fluorescence anisotropy profile after Bkg subtraction (r corrected) was obtained 
over a time range of at least 60 min.  
By this experimental approach we reached absolute DPH fluorescence 
anisotropy values of r = 0.17 - 0.25 and absolute TMA-DPH values of r = 0.24 - 
0.32 in adherent C6 cells. 
 
 
Figure 3.2.1-2: Typical time-dependent DPH and TMA-DPH fluorescence 
anisotropy (r) and intensity profile in adherent C6 cells, measured at a light angel 
of 30°. (Upper panel)  Fluorescence anisotropy profile of DPH and TMA-DPH presented 
as measured and corrected (after Bkg substraction) anisotropy value. (Lower panel) 
The corresponding intensities measured at vertical/vertical (vv) and vertical/horizontal 
(vh) polarization settings are presented as measured and corrected values (after Bkg 
subtraction). 
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By quantitative manipulation of membrane components that are known to achieve 
fluidity changes in a measureable way, the validity of the experimental setup can 
be evaluated. The significance of DPH and TMA-DPH fluorescence anisotropy 
changes as indicator of membrane fluidity alterations, was evaluated both by 
cholesterol depletion using methyl-β cyclodextrine (MβCD) and by increasing the 
phosphatidylcholine (PC) content by exposing C6 cells chronically (6 days) to an 
excess of choline (Figure 3.2.1-3 and Table 3.2.1). 
Cholesterol depletion, performed by incubation of C6 cells for 30 min at 37°C with 
10 mM MβCD, mediated significantly reduced DPH and TMA-DPH fluorescence 
anisotropy values, compared to the control. Under MβCD treatment DPH reached 
a stronger reduction to 0.815 ± 0.043**, compared to TMA-DPH with 0.933 ± 
0.008***.  
After chronic treatment (6 days) of C6 cells with 10 mM choline, we found a 
significant reduction of TMA-DPH fluorescence anisotropy values to 0.968 ± 
0.007** accompanied by the absence of an significant effect on DPH 
fluorescence anisotropy (Figure 3.2.1-3). 
 
 
 
Figure 3.2.1-3:  Relative change in DPH ( ) and TMA-DPH ( ) fluorescence 
anisotropy in adherent C6 cells after cholesterol depletion and PC enrichment. 
Cholesterol depletion was performed by incubation with 10 mM MßCD for 30 min. 
Enrichment of the PC content was performed by chronic incubation (6 days) with 10 mM 
choline. Results are presented as mean ± SEM. Marked values ** p ≤ 0.01 and *** p ≤ 
0.001 are significantly different from their corresponding controls, determined by the 
unpaired t-test. For corresponding values see Table 3.2.1. 
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Table 3.2.1: Corresponding values to Figure 3.2.1-3. Relative changes in DPH 
and TMA-DPH fluorescence anisotropy of adherent C6 cells chronically exposed 
to 10 mM choline for 6 days or 10 mM MßCD for 30 min. Marked values ** p ≤ 0.01 
and *** p ≤ 0.001 are significantly different from their corresponding controls, 
determined by the unpaired t-test. 
 mean ± SEM 
n-value of 
samples 
n-value of 
independent 
experiments 
DPH control 1.000 ± 0.022 13 9 
10 mM MßCD 0.815 ± 0.043** 3 3 
10 mM choline 0.981 ± 0.012 10 6 
TMA-DPH control 1.000 ± 0.004 21 10 
10 mM MßCD 0.933 ± 0.008*** 9 4 
10 mM choline 0.968 ± 0.007** 12 6 
 
 
3.2.2 Chronic incubation of C6 cells 
3.2.2.1 Stress hormones 
Since depression is strongly correlated to chronic stress, C6 cells were 
chronically (6-8 days) exposed to cortisol, dobutamine (β1-adrenergic receptor 
agonist) and terbutaline (β2-adrenergic receptor agonist). A concentration of 0.01-
1 µM cortisol induced a significant reduction in fluorescence anisotropy (Figure 
3.2.2.1-1 and Table 3.2.2.1-1).  For DPH fluorescence anisotropy values of 0.927 
± 0.021* for 0.01 µM cortisol, 0.928 ± 0.013*** for 0.1 µM cortisol and 0.889 ± 
0.022*** for 1 µM cortisol were determined.  For TMA-DPH a clear dose-
dependent reduction to non-significant 0.997 ± 0.020, followed by significant 
0.910 ± 0.015*** and 0.905 ± 0.014*** was observed for cortisol concentrations 
of 0.01, 0.1, and 1 µM, respectively.  
For β-adrenergic agonists we could not observe changes in membrane fluidity 
using DPH and TMA-DPH after chronic exposure to 0.1 µM and 1 µM of 
terbutaline and dobutamine, respectively (Figure 3.2.2.1-2 and Table 3.2.2.1-2).  
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Figure 3.2.2.1-1: Relative changes in DPH ( ) and TMA-DPH ( ) fluorescence 
anisotropy of adherent C6 cells chronically exposed (6-8 days) to cortisol. Results 
are presented as mean ± SEM. Marked values ** p ≤ 0.01 and *** p ≤ 0.001 are 
significantly different from their corresponding controls, determined by the unpaired t-
test. For corresponding values see Table 3.2.2.1-1. 
Table 3.2.2.1-1: Corresponding values to Figure 3.2.2.1-1. Relative changes in 
DPH and TMA-DPH fluorescence anisotropy of adherent C6 cells chronically 
exposed (6-8 days) to cortisol.  
Marked values ** p ≤ 0.01 and *** p ≤ 0.001 are significantly different from their 
corresponding controls, determined by the unpaired t-test. 
cortisol     mean ± SEM 
n-value of 
samples 
n-value of 
independent 
experiments 
DPH control 1.000 ± 0.006 25 15 
0.01 µM 0.927 ± 0.021* 7 5 
0.1 µM 0.928 ± 0.013*** 16 9 
1 µM 0.889 ± 0.022*** 8 6 
TMA-DPH control 1.000 ± 0.004 27 14 
0.01 µM 0.997 ± 0.020 7 4 
0.1 µM 0.910 ± 0.015*** 12 6 
1 µM 0.905 ± 0.014*** 13 7 
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Figure 3.2.2.1-2: Relative changes in DPH ( ) and TMA-DPH ( ) fluorescence 
anisotropy of adherent C6 cells chronically exposed (6-8 days) to dobutamine or 
terbutaline. Results are presented as mean ± SEM. For corresponding values see Table 
3.2.2.1-2. 
Table 3.2.2.1-2: Corresponding values of Figure 3.2.2.1-2. Relative changes in 
DPH and TMA-DPH fluorescence anisotropy of adherent C6 cells chronically 
exposed (6-8 days) to 0.1 µM and 1 µM dobutamine or terbutaline. 
dobutamine mean ± SEM 
n-value of 
samples 
n-value of 
independent 
experiments 
DPH control  1.000 ± 0.016 11 6 
0.1 µM 1.031 ± 0.037 5 4 
1 µM 1.009 ± 0.022 9 6 
TMA-DPH control  1.000 ± 0.005 12 6 
0.1 µM 1.026 ± 0.013 12 6 
1 µM 1.021 ± 0.010 11 6 
 terbutaline mean ± SEM 
n-value of 
samples 
n-value of 
independent 
experiments 
DPH control  1.000 ± 0.014 9 6 
0.1 µM 1.011 ± 0.019 9 6 
1 µM 0.993 ± 0.027 6 4 
TMA-DPH control  1.000 ± 0.012 8 4 
0.1 µM 1.026 ± 0.014 8 4 
1 µM 1.005 ± 0.017 7 4 
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3.2.2.2 Antidepressants 
Testing the chronic influence of standard antidepressants citalopram (selective 
serotonin reuptake inhibitor (SSRI)) at a concentration of 1 µM did not affect DPH 
and TMA-DPH fluorescence anisotropy. On the other side chronic incubation with 
1 µM desipramine (DMI, tricyclic antidepressant (TCA)) significantly increased 
DPH fluorescence anisotropy to 1.046 ± 0.008** compared to the corresponding 
control, while TMA-DPH fluorescence anisotropy was unchanged (Figure 3.2.2.2-
1 and Table 3.2.2.2-1). 
 
 
 
Figure 3.2.2.2-1:  Relative changes in DPH ( ) and TMA-DPH ( ) fluorescence 
anisotropy of adherent C6 cells chronically exposed (6-8 days) to 1 µM DMI or 1 
µM citalopram. Results are presented as mean ± SEM. For corresponding values see 
Table 3.2.2.2-1. 
Table 3.2.2.2-1: Corresponding values to Figure 3.2.2.2-1. Relative changes in 
DPH and TMA-DPH fluorescence anisotropy of adherent C6 cells chronically 
exposed (6-8 days) to 1 µM DMI or citalopram. 
                             synthetic         
                          antidepressants 
mean ± SEM 
n-value of 
samples 
n-value of 
independent 
experiments 
DPH control  1.000 ± 0.005 9 6 
1 µM DMI 1.046 ± 0.008** 6 4 
1 µM citalopram 1.003 ± 0.015 9 5 
TMA-DPH control  1.000 ± 0.017  10 5 
1 µM DMI 1.011 ± 0.009 10 5 
1 µM citalopram 1.011 ± 0.005 10 5 
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Chronic incubation with  Ze117 significantly increased DPH and TMA-DPH 
fluorescence anisotropy values of in C6 cells after 6-8 days of pretreatment, 
compared to their control (Figure 3.2.2.2-2 and Table 3.2.2.2-2). Fluorescence 
anisotropy measurements using DPH achieved a dose-dependent increase to 
1.080 ± 0.015**, 1.092 ± 0.013***, and 1.099 ± 0.010*** after incubation using 
concentrations of 0.01, 0.025, and 0.05 mg/ml Ze117, respectively. Identical 
incubation conditions revealed for TMA-DPH relative fluorescence anisotropy 
values of 1.041 ± 0.014*, 1.057 ± 0.013***, and 1.036 ±0.008**, respectively. 
 
 
Figure 3.2.2.2-2: Relative change in DPH ( ) and TMA-DPH ( ) fluorescence 
anisotropy of adherent C6 cells chronically exposed (6-8 days) to the Hypericum 
perforatum dried extract Ze117. Results are presented as mean ± SEM. Marked values 
* p ≤ 0.05, ** p ≤ 0.01 and *** p ≤ 0.001 are significantly different from their corresponding 
controls, determined by the unpaired t-test. For corresponding values see Table 3.2.2.2-
2. 
Table 3.2.2.2-2: Corresponding values to Figure 3.2.2.2-2. Relative changes in 
DPH and TMA-DPH fluorescence anisotropy of adherent C6 cells chronically 
exposed (6-8 days) to Ze117. Marked values * p ≤ 0.05, ** p ≤ 0.01 and *** p ≤ 
0.001 are significantly different from their corresponding controls, determined by the 
unpaired t-test. 
Ze117 mean ± SEM 
n-value of 
samples 
n-value of 
independent 
experiments 
DPH control 1.000 ± 0.006 25 15 
0.01 mg/ml 1.080 ± 0.015** 10 6 
0.025 mg/ml 1.092 ± 0.013*** 13 8 
0.05 mg/ml 1.099 ± 0.010*** 16 11 
TMA-DPH control 1.000 ± 0.005 28 14 
0.01 mg/ml 1.041 ± 0.014* 10 5 
0.025 mg/ml 1.057 ± 0.013*** 15 9 
0.05 mg/ml 1.036 ± 0.008** 16 9 
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3.2.2.3 Bioactive ingredients of Ze117 
For Hypericum perforatum a variety of bioactive ingredients have been described 
to contribute to the antidepressant effect, including hypericin, hyperforin and 
several flavonoids (Linde, 2009). Following chronic incubation (6-8 days) of C6 
cells to such single substances an anisotropy increasing effect could be assigned 
at least to hypericin, hyperforin, quercetin, amentoflavone and biapigenin. With 
the exception to rutin, actually all tested substances induced an increase of the 
DPH and TMA-DPH fluorescence anisotropy compared to the control.  
Chronic incubation (6-8 days) with hypericin at a concentration range of 0.01 µM 
and  0.1 µM mediated significantly increased DPH fluorescence anisotropy 
values dose-dependently to 1.039 ± 0.013*, and 1.079 ± 0.013***, while TMA-
DPH  fluorescence anisotropy reached values of 1.049 ± 0.016**, and 1.039 ± 
0.012**, respectively. A concentration of 0.001 µM showed no effect (Figure 
3.2.2.3-1A and Table 3.2.2.3-1). 
Chronic incubation (6-8 days) with hyperforin gained a dose-dependent increase 
in DPH fluorescence anisotropy to 1.084 ± 0.033*, 1.053 ± 0.019*, and 1.108 ± 
0.022*** by concentrations of 0.01 µM, 0.1 µM, and 1 µM. Parallel TMA-DPH 
fluorescence anisotropy measurements showed only at the highest concentration 
of 1 µM hyperforin a significantly increased value to 1.059 ± 0.013*** (Figure 
3.2.2.3-1B and Table 3.2.2.3-1). 
 
 
Figure 3.2.2.3-1: Relative change in DPH ( ) and TMA-DPH ( ) fluorescence 
anisotropy in adherent C6 cells after chronic incubation (6-8 days) with hypericin 
and hyperforin. Results are presented as mean ± SEM. Marked values * p ≤ 0.05, ** p 
≤ 0.01 and *** p ≤ 0.001 are significantly different from their corresponding controls, 
determined by the unpaired t-test. For corresponding values see Table 3.2.2.3-1.  
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Table 3.2.2.3-1: Corresponding values to Figure 3.2.2.3-1. Relative changes in 
DPH and TMA-DPH fluorescence anisotropy of adherent C6 cells chronically 
exposed (6-8 days) to hypericin and hyperforin. Marked values * p ≤ 0.05, ** p ≤ 
0.01 and *** p ≤ 0.001 are significantly different from their corresponding controls, 
determined by the unpaired t-test. 
hypericin mean ± SEM 
n-value of 
samples 
n-value of 
independent 
experiments 
DPH control  1.000 ± 0.006 20 12 
0.001 µM 0.981 ± 0.020  6 4 
0.01 µM 1.039 ± 0.013* 8 6 
0.1 µM 1.079 ± 0.013*** 14 11 
TMA-DPH control 1.000 ± 0.006 17 9 
0.001 µM 0.991 ± 0.011 10 5 
0.01 µM 1.049 ± 0.016** 10 6 
0.1 µM 1.039 ± 0.012** 13 7 
 hyperforin mean ± SEM 
n-value of 
samples 
n-value of 
independent 
experiments 
DPH control  1.000 ± 0.006 13 7 
0.01 µM 1.084 ± 0.033* 4 3 
0.1 µM 1.053 ± 0.019* 10 5 
1 µM 1.108 ± 0.022*** 7 4 
TMA-DPH control   1.000 ± 0.008 19 10 
0.01 µM 0.998 ± 0.012 9 5 
0.1 µM 1.002 ± 0.012 16 9 
1 µM 1.059 ± 0.013*** 16 9 
 
 
Chronic exposure (6-8 days) of C6 cells to the flavonoid quercetin in 
concentrations of 0.5 µM, 1 µM, and 1.5 µM induced an dose-dependent increase 
of the relative DPH fluorescence anisotropy to 1.016 ± 0.028 and statistical 
significant 1.067 ± 0.019* and 1.112 ± 0.012**, respectively. The same 
concentrations of 0.5 - 1.5 µM quercetin changed the TMA-DPH fluorescence 
anisotropy to 1.031 ± 0.016, 1.032 ± 0.008***, and statistically significant 1.028 ± 
0.012*, compared to their corresponding controls (Figure 3.2.2.3-2B and Table 
3.2.2.3-2). Rutin, which was tested at a concentration of 1 µM, showed no 
changes (Figure 3.2.2.3-2A and Table 3.2.2.3-2). 
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Figure 3.2.2.3-2: Relative changes in DPH ( ) and TMA-DPH ( ) fluorescence 
anisotropy values of adherent C6 cells chronically exposed (6-8 days) to rutin or 
quercetin. Results were pooled and are presented as mean ± SEM. Marked values * p 
≤ 0.05, ** p ≤ 0.01 and *** p ≤ 0.001 are significantly different from their corresponding 
controls, determined by the unpaired t-test. For corresponding values see Table 3.2.2.3-
2. 
 
 
Table 3.2.2.3-2: Corresponding values to Figure 3.2.2.3-2. Relative changes in 
DPH and TMA-DPH fluorescence anisotropy of adherent C6 cells chronically 
exposed (6-8 days) to rutin or quercetin. Marked values * p ≤ 0.05, ** p ≤ 0.01 and 
*** p ≤ 0.001 are significantly different from their corresponding controls, determined 
by the unpaired t-test. 
 rutin mean ± SEM 
n-value of 
samples 
n-value of 
independent 
experiments 
DPH control 1.000 ± 0.020 10 6 
1 µM 1.031 ± 0.023 9 6 
TMA-DPH control 1.000 ± 0.004 20 11 
1 µM 1.015 ± 0.011 19 11 
 quercetin mean ± SEM 
n-value of 
samples 
n-value of 
independent 
experiments 
DPH control  1.000 ± 0.012 26 15 
0.5 µM 1.016 ± 0.028 5 3 
1 µM 1.067 ± 0.019* 11 7 
1.5 µM 1.112 ± 0.012** 9 7 
TMA-DPH control  1.000 ± 0.004 40 20 
0.5 µM 1.031 ± 0.016 10 5 
1 µM 1.032 ± 0.008*** 21 12 
1.5 µM 1.028 ± 0.012* 16 9 
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The biflavonoid amentoflavone, which was also examined at a concentration 
range of 0.5 - 1.5 µM exposed a dose-dependent increase in DPH fluorescence 
anisotropy, which reached statistical significance at the highest concentration of 
1.5 µM with an increase to 1.082 ± 0.033*. Statistical significance was also seen 
in TMA-DPH fluorescence anisotropy, which reached a value of 1.041 ± 0.013* 
after chronic incubation to 1.5 µM amentoflavone (Figure 3.2.2.3-3A and Table 
3.2.2.3-3).  
Chronic incubation (6-8 days) with the biflavonoid biapigenin showed statistic 
significant alterations of DPH fluorescence anisotropy to 1.087 ± 0.018** by 1 µM 
and 1.101 ± 0.016** by 1.5 µM. For TMA-DPH no effect was observed compared 
to the control (Figure 3.2.2.3-3B and Table 3.2.2.3-3). 
 
 
 
 
 
Figure 3.2.2.3-3: Relative changes in DPH ( ) and TMA-DPH ( ) fluorescence 
anisotropy values of adherent C6 cells chronically exposed (6-8 days) to 
amentoflavone or biapigenin. Results are presented as mean ± SEM. Marked values 
** p ≤ 0.01 and *** p ≤ 0.001 are significantly different from their corresponding controls, 
determined by the unpaired t-test. For corresponding values see Table 3.2.2.3-3. 
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Table 3.2.2.3-3: Corresponding values to Figure 3.2.2.3-3. Relative changes in 
DPH and TMA-DPH fluorescence anisotropy of adherent C6 cells chronically 
exposed (6-8 days) to amentoflavone or biapigenin. Marked values ** p ≤ 0.01 and 
*** p ≤ 0.001 are significantly different from their corresponding controls, determined 
by the unpaired t-test. 
amentoflavone mean ± SEM 
n-value of 
samples 
n-value of 
independent 
experiments 
DPH control 1.000 ± 0.014 30 17 
0.5 µM 1.016 ± 0.020 6 4 
1 µM 1.044 ± 0.013 8 5 
1.5 µM 1.082 ± 0.033* 11 7 
TMA-DPH control 1.000 ± 0.005 40 21 
0.5 µM 1.015 ± 0.012 11 6 
1 µM 0.995 ± 0.008 19 11 
1.5 µM 1.041 ± 0.013* 12 7 
biapigenin mean ± SEM 
n-value of 
samples 
n-value of 
independent 
experiments 
DPH control 1.000 ± 0.011 25 16 
0.5 µM 1.031 ± 0.017 7 4 
1 µM 1.087 ± 0.018** 12 8 
1.5 µM 1.101 ± 0.016** 8 5 
TMA-DPH control 1.000 ± 0.005 29 15 
0.5 µM 0.967 ± 0.017 9 5 
1 µM 0.991 ± 0.012 16 9 
1.5 µM 1.026 ± 0.014 8 4 
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3.2.2.4 Acute incubation of C6 cells 
To proper distinguish between a chronic and a possible direct membrane 
interacting effect associated with changes in membrane fluidity an additional 
acute exposure approach was performed. Adherent C6 cells were treated for 1 h 
with several substances under investigation. The following washing, background 
determination, DPH or TMA-DPH labeling and measurement procedure were 
identical for both, the acute and the chronic approach. With the exception of 
cortisol, all substances under investigation showed no direct membrane-
interacting mediated effect on DPH and TMA-DPH fluorescence anisotropy 
(Figure 3.2.2.4 and Table 3.2.2.4). Acute incubation with 1 µM cortisol induced a 
small but significant increased TMA-DPH fluorescence anisotropy value to 1.033 
± 0.011**.  
 
 
Figure 3.2.2.4: Relative changes in DPH ( ) and TMA-DPH ( ) fluorescence 
anisotropy values of adherent C6 cells after acute exposer (1 h) to several test 
substances under investigation. Results are presented as mean ± SEM. Marked 
values ** p ≤ 0.01 are significantly different from their corresponding controls, determined 
by the unpaired t-test. For corresponding values see Table 3.2.2.4 
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Table 3.2.2.4: Correspondng values to Figure 3.2.2.4. Relative changes in DPH 
and TMA-DPH fluorescence anisotropy of adherent C6 cells acutely exposed 
for 1h to several substances under investigation. 
 
 control substances mean ± SEM 
n-value of 
samples 
n-value of 
independent 
experiments 
DPH control 1.000 ± 0.007 19 10 
1 µM cortisol 1.015 ± 0.026 14 8 
1 µM terbutaline 1.011 ± 0.022 11 7 
1 µM dobutamine 1.010 ± 0.025 11 7 
1 µM DMI 0.981 ± 0.026 15 9 
1 µM citalopram 0.990 ± 0.023 11 6 
TMA-DPH control 1.000 ± 0.009 22 10 
1 µM cortisol 1.033 ± 0.011** 14 7 
1 µM terbutaline 1.004 ± 0.013 9 5 
1 µM dobutamine 1.010 ± 0.012 10 5 
1 µM DMI 1.033 ± 0.016 14 7 
1 µM citalopram 0.997 ± 0.010 13 7 
 
Ze117 and ingredients mean ± SEM 
n-value of 
samples 
n-value of 
independent 
experiments 
DPH control  1.000 ± 0.007 19 10 
0.05 mg/ml Ze117 1.017 ± 0.021 11 6 
0.1 µM hypericin 1.046 ± 0.023 11 7 
1 µM hyperforin 1.049 ± 0.024 11 6 
1µM rutin 1.023 ± 0.025 11 8 
1.5 µM quercetin 1.042 ± 0.023 12 7 
1.5µM amentoflavone 1.047 ± 0.024 14 8 
1.5 µM biapigenin 1.022 ± 0.021 11 6 
TMA-DPH control  1.000 ± 0.010 20 9 
0.05 mg/ml Ze117 1.013 ± 0.019 16 8 
0.1 µM hypericin 1.028 ± 0.014 14 7 
1 µM hyperforin 0.999 ± 0.017 15 8 
1 µM rutin 1.004 ± 0.014 11 6 
1.5 µM quercetin 0.990 ± 0.010 16 8 
1.5 µM amentoflavone 1.015 ± 0.012 10 6 
1.5 µM biapigenin 1.022 ± 0.013 11 6 
 
 
 
 
 
  
                                                                                                                                                              Results 
 
37 
 
3.3 Assessment of changes within the PC/PE ratio of C6 cells  
by TLC 
To examine possible changes within the phospholipid composition, associated to 
membrane fluidity changes, we investigated the phosphatidylcholine to 
phosphatidylethanolamine (PC/PE) ratio of C6 cells using thin layer 
chromatography (TLC). In comparison to control we found a significant increase 
in the PC/PE ratio to 1.343 ± 0.078*** following chronic incubation (6 days) with 
10 mM choline and a significant reduction in the PC/PE ratio to 0.819 ± 0.075** 
after chronic treatment with 1 µM cortisol. Ze117 also revealed a reducing effect 
on the PC/PE ratio. This effect was dose-dependent for the analyzed 
concentrations of 0.01 - 0.05 mg/ml and reached statistical significance at the 
highest concentration of 0.05 mg/ml Ze117 with 0.866 ± 0.055**. In contrast, 
chronic treatment with 1 µM DMI and 1 µM citalopram did not affect the PC/PE 
ratio (Figure 3.3 and Table 3.3). 
 
 
 
Figure 3.3:  Relative change in the PC/PE ratio within whole cell lipid extracts 
derived from C6 cells chronically incubated (6 days) with 1 µM cortisol, 1 µM DMI, 
1 µM citalopram or 0.01-0.05 mg/ml Ze117, determined by densitometric TLC. 
Results are presented as mean ± SEM. Marked values ** p ≤ 0.01 and *** p ≤ 0.001 are 
significantly different from their corresponding controls, determined by the unpaired t-
test.  For corresponding values see Table 3.3. 
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Table 3.3: Corresponding values of Figure 3.3. Relative change in the PC/PE 
ratio within whole cell lipid extracts derived from C6 cells chronically treated (6 
days) with 1 µM cortisol, 1 µM DMI, 1 µM citalopram, or 0.01 - 0.05 mg/ml Ze117 
analyzed by densitometric TLC.  Marked values ** p ≤ 0.01 are significantly different 
from their corresponding controls, determined by the unpaired t-test.  
  mean ± SEM n-value of samples 
Control 1.000 ± 0.027 13 
0.01 mg/ml Ze117 0.980 ± 0.104 5 
0.025 mg/ml Ze117 0.923 ± 0.099 4 
0.05 mg/ml Ze117    0.866 ± 0.055** 5 
1 µM DMI 1.074 ± 0.133 4 
1 µM citalopram 1.082 ± 0.127 4 
1 µM cortisol    0.819 ± 0.075** 4 
10 mM choline      1.343  ± 0.078*** 4 
 
 
3.4 PC pulse-chase and PC identification 
Observing a generally reduced PC/PE ratio after chronic exposure to cortisol and 
Ze117 we focused closer to the question whether a suggested reduction in PC 
may result from a general reduction of the whole PC pool or a selective reduction 
affecting only specific PC species. This question was experimentally approached 
by exposure of C6 cells to 50 µM choline-D9 for 24 h, which becomes 
incorporated into PC via the de-novo biosynthesis pathway and subsequently is 
detectable by mass spectrometric analysis. As presented in Figure 3.4-1 mass 
spectrometric analysis allowed the detection of the most prominent PC species 
([M+H]+) with m/z = 732, 754, 758, 760, 782, 786, and 808 by the appearance of 
their deuterated derivatives with m/z = 741, 763, 767, 769, 791, 795, and 817 
within whole cell lipid extracts.  
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Figure 3.4-1: Positive mode mass spectra of whole cell lipid extracts derived from 
C6 control cells with and without 24 h exposure to 50 µM choline-D9. The 
incorporation of choline-D9 into PC via the de-novo biosynthesis pathway results in the 
appearance of deuterated PC derivatives (red) of corresponding natural occurring PC 
species (blue). These PC pairs expose a mass difference of 9 resulting from the 3 
deuterated methyl groups of choline-D9.   
 
 
The identities of these pairs as PC species were confirmed by positive mode MS2 
fragmentation (+MS2) (Table 3.4-1 and appendix, Figure 6.1). Neutral loss of the 
head group (phosphocholine with m/z = 183, phosphocholine-D9 with m/z = 192) 
results in the presence of a diacylglycerol (DAG)-like fragment which is identical 
for the natural and the deuterated PC species (Figure 3.4-2). Neutral loss of 
choline (with m/z = 59) or choline-D9 (with m/z = 68 m/z) from the parent ion was 
also examined. 
[M+H]+ 
[M+H]+ 
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Figure 3.4-2: Positive mode fragmentation principle of PC pairs presented on the 
example of AoPPC (20:4/16:0). (Upper panel) Natural occurring PC species and their 
deuterated derivatives were identified as PC pair within +MS2 by forming an identical 
DAG-like fragment by neutral loss of the head group (phosphocholine with m/z = 183, 
phosphocholine-D9 with m/z = 192). The loss of choline (-59 m/z) or choline-D9 (-68 m/z) 
from the parent ion can also be examined. Adapted from 
www.byrdwell.com/PhosphatidylCholine/PCfragments 
(Lower panel) corresponding +MS2 spectrum. 
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Tabele 3.4-1: Conformation of main species and their deuterated derivatives as 
actual PC species, performed by positive mode MS2 fragmentation. PC-pairs 
are identified within the +MS2 by forming an identical DAG-like fragment by neutral 
loss of the head group (phosphocholine with m/z = 183, phosphocholine-D9 with m/z 
= 192 m/z). The loss of choline (with m/z = 59) or choline-D9 (with m/z = 68) from the 
parent ion can also be examined. 
+MS  +MS2 
[M+H]+  
DAG-like fragment after 
neutral loss of head group 
PC fragment after 
neutral loss of trimethylamine 
732 
741 
 
549 
549 
673  
673 
754 
763 
 
571 
571 
695 
695 
758 
767 
 
575 
575 
699 
699 
760 
769 
 
577 
577 
701  
n.d. 
782 
791 
 
599 
599 
723 
723 
786 
795 
 
603 
603 
727 
727 
808 
817 
 
625 
625 
749 
749 
n.d. = not detected 
 
Approaching changed synthesis kinetics of these main PC species after chronic 
treatment (6 days) with antidepressants and cortisol, C6 cells were co-exposed 
to 50 µM choline-D9 for the last 24 h of incubation. Chronic incubation (6 days) 
with 1 µM DMI, 1 µM citalopram or 1 µM cortisol showed no significant alteration 
in the choline-D9 incorporation rate within the examined main PC species, 
compared to control (Table 3.4-2). Following chronic incubation with 0.05 mg/ml 
Ze117 a significant reduction of the choline-D9 content was observed within 
specific PC species with m/z = 732, 758, 760, and 786. In detail, the choline-D9 
bearing PC content was reduced for the PC species with m/z = 732 by 24% (from 
50.8% to 38.5%***), m/z = 758 by 37% (from 47.5% to 30.1%***), m/z = 760 by 
17% (from 52.4 to 43.7%***), and m/z = 786 by 9% (from 53.5% to 48.7%**) 
(Table 3.4-2).  
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Table 3.4-2: Deuterated content in percent within main PC species after 24 h 
co- exposure to 50 µM choline-D9 of C6 cells chronically incubated (6 days) 
with Ze117, antidepressants or cortisol. Marked values ** p ≤ 0.01 and *** p ≤ 
0.001 are significantly different from their corresponding controls determined by the 
unpaired t-test.  .   
[M+H]+  732D9 754D9 758D9 760D9 782D9 786D9 808D9 
Control mean 
SEM 
N 
50.8 
± 0.75 
16 
58.3 
± 0.66 
16 
47.5 
± 1.02 
13 
52.4 
± 0.53 
16 
55.7 
± 0.60 
16 
53.5 
± 0.49 
16 
53.2 
± 0.57 
16 
Ze117 
0.05 mg/ml 
mean 
SEM 
N 
38.5*** 
± 1.45 
7 
57.1 
± 2.72 
6 
30.1*** 
± 1.35 
7 
43.7*** 
± 1.08 
7 
54.3 
± 1.94 
7 
48.7** 
± 1.28 
7 
51.1 
± 1.82 
7 
DMI 
1 µM 
mean 
SEM 
N 
50.6 
± 0.92 
6 
57.3 
± 0.81 
6 
47.1 
± 1.35 
5 
50.9 
± 1.30 
6 
53.3 
± 1.12 
6 
51.3 
± 0.90 
6 
52.5 
± 1.46 
6 
Citalopram 
1 µM 
mean 
SEM 
N 
51.1 
± 1.90 
5 
58.2 
± 0.55 
5 
47.0 
± 2.55 
5 
51.9 
± 1.38 
5 
54.6 
± 0.44 
5 
51.9 
± 1.41 
5 
53.0 
± 1.04 
5 
Cortisol 
1 µM 
mean 
SEM 
N 
49.4 
± 1.67 
7 
58.0 
± 0.71 
7 
44.9 
± 2.15 
6 
49.8 
± 1.15 
7 
53.9 
± 0.34 
7 
49.9 
± 1.08 
7 
52.8 
± 0.54 
7 
 
 
Subsequent these PC-species become characterized by their fatty acid 
composition by negative mode fragmentation (Figure 3.4-4) which allowed the 
identification of these PC species affected by Ze117 as PPoPC (16:0/16:1), 
MOPC (14:0/18:1), PoOPC (16:1/18:1), POPC (16:0/18:1), and Di-OPC 
(18:1/18:1) (Table 3.4-4 and appendix, Figure 6.2). The remaining PC species, 
not affected by Ze117, have been identified as polyunsaturated fatty acid (PUFA) 
bearing PC species with m/z = 782 represents PAoPC (16:0/20:4) and PohLPC 
(16:1/20:3) and m/z = 808 could be identified as OAoPC (18:1/20:4). These PUFA 
bearing PC species were observed with a much lower abundancy within the 
negative mode, compared to positive mode MS spectra (compare Figure 3.4-1 
and Figure 3.4-3). As a consequence of this phenomenon the PC species with 
m/z = 754 [M+H]+, which had already the lowest intensity within the positive 
mode, became undetectable within negative mode observations. However, online 
data base analysis strongly suggest the PC species PoLnPC (16:1/18:3) to be 
presented by m/z = 754 [M+H]+ as the PC species bearing the fatty acid 
combination  16:0/18:4 is rare. 
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Figure 3.4-3: Negative mode mass spectrum of whole cell lipid extracts derived 
from C6 cells. Main PC species previously investigated at positive mode as [M+H]+ 
cations are detected within the negative mode as anionic chloride [M+Cl]- (upper panel) 
or acetate [M+CH3COO]- adduct (lower panel). The PC species with m/z = 754 [M+H]+ 
calculated to expose a m/z of 812 [M+CH3COO]-  was not detected within negative mode 
observations. The corresponding [M+Cl]-  adduct calculated to expose a m/z of 788, if 
present overlies with phosphatidylserine (18:0/18:1) at 788.54 m/z present in both 
negative mode spectra. 
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Figure 3.4-4: Negative mode fragmentation of anionic PC adducts for fatty acid 
identification. Fragmentation presented by the example of the PoOPC (16:1/18:1) 
chloride adduct.  The PC adduct becomes fragmented resulting in a [M-CH3]–  fragment, 
which is further fragmented allowing fatty acid identification. The sn-2 fatty acid fragment 
[R2COO]- is distinguished from the sn-1 fatty acid fragment [R1COO]-  due to it appears 
with a higher abundancy within the MS3 spectrum. 
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Table 3.4-3: PC species identification.   Parental masses of examined main PC 
species within the positive mode allowed assumption of possible fatty acid 
combinations. 
Actual fatty acid composition was examined by negative mode MS3 (- MS3) 
fragmentation of [M+Cl]- or [M+CH3COO]- according to Figure 3.4-4.  
+MS  - MS3 PC species 
Parental 
mass 
Possible PC 
species* 
Fatty acid fragment Identified 
732 
PPoPC (16:0 /16:1) 
MOPC (14:0/18:1) 
 
227 (14:0) 
253 (16:1) 
255 (16:0) 
281 (18:1) 
 
PPoPC (16:0/16:1) 
MOPC (14:0/18:1) 
754 PoLnPC (16:1/18:3)  n.d.   
758 
PLPC (16:0 /18:2) 
PoOPC (16:1/18:1) 
 
281 (18:1) 
253 (16:1) 
 PoOPC (16:1/18:1) 
760 
POPC (16:0/18:1) 
PoSPC (16:1/18:0) 
 
281 (18:1) 
255 (16:0) 
 POPC (16:0/18:1) 
782 
PAoPC (16:0/20:4) 
PohLPC  (16:1/20:3) 
Di-LPC (18:2/18:2) 
 
255 (16:0) 
253 (16:1) 
305 (20:3) 
303 (20:4) 
 
PAoPC (16:0/20:4) 
PohLPC  (16:1/20:3) 
786 
PoGPC (16:1/20:1) 
SLPC (18:0/18:2) 
Di-OPC (18:1/18:1) 
 281 (18:1)  Di-OPC(18:1/18:1) 
808 
OAoPC (18:1/20:4) 
LhLPC (18:2/20:3) 
 
281 (18:1) 
303 (20:4) 
 OAoPC (18:1/20:4) 
M; myristic acid (14:0), P; palmic acid (16:0), Po; palmitoleic acid (16:1), S; stearic acid 
(18:0), O; oleic acid  or elaidic acid (18:1), L; linoleic acid (18:2), Ln; linolenic acid (18:3), 
G; gadoleic acid or gondoic acid (20:1),  hL; homo-g-linolenic (20:3), Ao; arachidonic 
acid (20:4). 
* www.byrdwell.com/PhosphatidylCholine/FattyAcids  
n.d. = not detected  
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4 Discussion 
4.1 DPH and TMA-DPH fluorescence anisotropy measurements 
in adherent C6 cells  
 
Within this study, changes of the plasma membrane fluidity of C6 cells were 
assessed by fluorescence anisotropy measurements. For this approach DPH 
(1,6-diphenyl-1,3,5-hexatriene) and its derivative TMA-DPH (1-(4-
(trimethylamino)phenyl)-6-phenylhexa-1,3,5-triene) were applied as fluorescent 
probes which spontaneously partitioning into the membrane and gauge the 
movement of their surrounding microenvironment. The DPH molecule is one of 
the most favorable probes for polarization studies due its low solubility and 
quenched emission in water (Lakowicz, 2006; Li et al., 2000; Loura & Ramalho 
2011). DPH is readily soluble in the hydrocarbon core, where the fluorescence 
originates from the hydrophobic milieu within deeper portions of the membrane 
bilayer (Aricha et al., 2004; Lakowicz, 2006; Repakova et al., 2005). The 
orientation of DPH within the membrane is favored parallel to the middle region 
of the hydrocarbon acyl chains of the phospholipids of the outer bilayer leaflet 
(Figure 4.1) (Aricha et al., 2004; Repakova et al., 2005; Nelson et al., 2012; 
Fraňová et al., 2010). This orientation of the rod like structured molecule makes 
DPH very sensitive to changes of the angular reorientation of the long axis of the 
neighboring lipophilic acyl chain environment (Loura & Ramalho, 2011; Aricha et 
al., 2004). The DPH derivative TMA-DPH was designed to anchor itself with its 
charged trimethylammonium group to the membrane/water interface. TMA-DPH 
is therefore proposed to allow the determination of rotational changes more close 
to the phospholipid head group region (do Canto et al., 2016; Fišar et al., 2005). 
                   
Figure 4.1:  Chemical structure and schematic membrane incorporation of DPH 
and TMA-DPH.  
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Fluorescence anisotropy measurements were performed on adherent C6 cells 
applying an incident light angle of 30° relative to the cell monolayer. This angle 
directs reflected light away from the detector leading to minimized background 
signal (Bkg) and more reliable anisotropy measurements, compared to the 
usually used “magic angle” of 45° (Sumbilla & Lakowicz, 1983; Lakowicz 2006). 
In order to allow accurate interpretation of DPH and TMA-DPH fluorescence 
anisotropy changes, this experimental setup was finally evaluated by membrane 
fluidity manipulation.  
In order to examine the actual sensitivity of TMA-DPH to membrane fluidity 
changes within the phospholipid head group region selective enrichment of the 
phosphatidylcholine (PC) content was performed by increasing choline 
availability, which as the starting substrate of the PC de-novo pathway becomes 
incorporated as the choline head group (Jamil & Vance, 1990; Fagone & 
Jackowski, 2013). Following chronic incubation of C6 cells with choline a 
significant increase of the PC/PE ratio by 33 % within whole cell lipid extracts 
correlated to a small but significantly decreased TMA-DPH fluorescence 
anisotropy value. These observation correlates to what is described in literature 
for the relationship between membrane fluidity and PC/PE ratio (Fajardo et al., 
2011). 
PC represents a main bilayer-forming phospholipid class, making up to 50 % of 
the phospholipid content (van Meer, 2005; Mitchel et al., 2007). The spatial 
cylindrical shaped choline head group and its hydration status negates tight 
packing of adjacent hydrophobic lipids and proteins and therefore enhances 
membrane fluidity (Fajardo et al., 2011; Seu et al., 2006). 
Phosphatidylethanolamine (PE), the second most prominent phospholipid class, 
restricts movement and thereby decreases membrane fluidity (Fajardo et al., 
2011, Seu et al., 2006). The smaller ethanolamine head group for once allows 
tighter packaging and also interacts as hydrogen donor with anionic phosphate-
oxygen of adjacent phospholipids (Fajardo et al., 2011, Seu et al., 2006). 
Under identical conditions for DPH fluorescence anisotropy a not significant 
tendency toward an increased membrane fluidity was found. This small tendency 
of the DPH fluorescence anisotropy may be explained by lighter phospholipid 
packaging mediated by the increased PC content. Therefore, a selective 
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sensitivity of TMA-DPH but not DPH to changes of the head group region 
membrane fluidity could be confirmed within own measurements. 
 
The general sensitivity of DPH and TMA-DPH to membrane fluidity changes 
within our experimental setup was examined by cholesterol depletion using well 
established methyl-β-cyclodextrine (MβCD) (Hebbar et al., 2008; Zidovetzki & 
Levitan, 2007). Decreasing the membrane cholesterol content led to decreased 
fluorescence anisotropy values corresponding to an increase in membrane 
fluidity in C6 cells. This effect was more pronounced for DPH than for TMA-DPH. 
A comparable observation following a similar approach in bovine hippocampal 
membranes was made by Pucadyil & Chattopadhyay (2004). Since cholesterol 
affects the rotational freedom of PC and sphingomyelin (SM) head group 
structures (Ramstedt & Slotte, 2002) and especially fatty acids (Chen et al., 1999) 
the more pronounced effect seen for DPH is suggested to result at least from 
immediate local proximity to cholesterol within the hydrophobic core. On the other 
side TMA-DPH, which is anchored by its polar trimethylamine group, generally 
shows movement restriction and lower sensitivity to changes in the membrane 
fluidity, compared to the more lipophilic DPH molecule (Haertel, 2000; Mulders et 
al., 1986).  
Although TMA-DPH is supposed to report changes next to the head group region, 
more recent work identified TMA-DPH to mediate only a minimal positioning 
change of the DPH fluorophore towards a more external membrane depth (do 
Canto et al., 2016; Nelson et al., 2012). As a result of this minimal difference in 
membrane depth, TMA-DPH has been suggested to actually being sensitive to 
at least the glycerol backbone and the upper fatty acids segments and basically 
report similar changes as DPH (do Canto et al., 2016; Nelson et al., 2012). 
However own results support the idea that these two probes are feasible to 
distinguish between effects working on lipid head groups (TMA-DPH) from those 
working more on the lipid core (DPH).  
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4.2 Adaptive changes within membrane fluidity following chronic 
incubation of C6 cells with stress hormones 
By now, a significant association between stress and depression is well 
documented (Tafet et al., 2001). Therefore, the influence of cortisol and 
alternatively to adrenaline (due to low stability in aqueous solution) terbutaline 
(β2-adrenergic receptor (β2-AR) specific agonist) and dobutamine (β1-AR 
specific agonist) on C6 cell plasma membrane fluidity was investigated. In order 
to investigate adaptive changes on membrane fluidity C6 cells were incubated 
for a chronic (6-8 days) time period. 
Following chronic incubation with cortisol a dose-dependent membrane fluidity 
enhancement was determined by decreased fluorescence anisotropy values 
seen for both DPH and TMA-DPH. Obviously, chronic incubation with cortisol 
induced adaptive changes in membrane properties, as acute incubation induced 
an opposite membrane rigidification effect within the head group region of the 
plasma membrane only, examined by an increased TMA-DPH fluorescence 
anisotropy. Such a cortisol mediated adaptive enhancement in membrane 
fluidity, measured by decreased DPH fluorescence anisotropy values was also 
described in human lymphocytes (Tolentino et al., 1991). 
Own in parallel performed lipid analyses showed a decreased PC/PE ratio within 
C6 whole cell lipid extracts following chronic incubation with cortisol. This 
decrease in PC/PE ratio does however not correlate with the examined 
membrane fluidity increasing effect, determined by TMA-DPH fluorescence 
anisotropy. The examined cortisol induced enhancement in membrane fluidity, 
measured by DPH and TMA-DPH fluorescence anisotropy therefore suggest an 
underlying increase in membrane core fluidity. 
Unfortunately, we found no comparable approach focusing on cortisol mediated 
adaptive changes in membrane fluidity and associated changes in membrane 
composition. However, similar studies applying the chemically similar synthetic 
glucocorticoid dexamethasone (16α-methyl-cortisol) have also demonstrated 
an adaptive enhancement of membrane fluidity in HeLa cells, rat liver cells and 
intestinal membranes. Within these studies a decreased DPH fluorescence 
anisotropy seemed to correlate with cell type specific changes including an 
increase polyunsaturated fatty acid (PUFA) index (Brasitus et al., 1987; 
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Kapitulnik et al., 1986) and a decreased cholesterol/protein ratio (Johnston & 
Melnykovych 1980; Johnston et al., 1980).  
A possible selective reduction of PC species, bearing length-chain and highly 
saturated fatty acid moieties, may theoretically contribute to the examined 
cortisol induced enhancement of C6 cell membrane fluidity. Mass analysis 
revealed however a small but nonsignificant decreased choline-D9 
incorporation within all main PC-species under investigation. The decreased 
PC/PE ratio in C6 cells seems therefore to result from a general small decrease 
in PC synthesis and a suggested increase in PE content. It is therefore highly 
suggested that cortisol induce a decreased cholesterol content and / or selective 
changes in fatty acid composition within remaining phospholipid classes 
associated to induce the examined C6 cell membrane fluidity enhancement.   
Neither acute nor chronic incubation with 1 µM terbutaline or dobutamine did 
affect DPH and TMA-DPH fluorescence anisotropy in C6 cells. Within literature 
no chronic investigations on membrane fluidity were found.  
However a rather acute approach in human adult fibroblasts identified an 
increased membrane fluidity after 1 h treatment with adrenaline by fluorescence 
recovery after photobleaching (Eggl et al., 1986). Corresponding lipid analysis 
applying 32P labeling identified a reduced PC and an increased PE synthesis 
accompanied by a reduced 18:1 fatt acid content of PE (Eggl et al., 1986). Rats 
injected with increasing amounts of norepinephrine for up to 2 weeks showed 
altered cardiac fatty acid composition of phosphatidylcholine and 
phosphatidylethanolamine, whereas the other lipid classes were affected only 
weakly (Emilsson & Gudbjarnason, 1983). This included a reduction of PC 
monounsaturated fatty acids (16:1 and 18:1) (Emilsson & Gudbjarnason, 1983). 
And a partial replacement of linoleic acid (18:2) by arachidonic acid (20:4) in 
PC and replacement of both 18:2 and 20:4 by docosahexaenoic acid (22:6) in 
PE (Gudbjamason & Benediktsdottir, 1996; Emilsson & Gudbjarnason, 1983). 
As chronic treatment with terbutaline and dobutamine did not change DPH and 
TMA-DPH fluorescence anisotropy in C6 cells no corresponding lipid analysis 
was performed within this work. 
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4.3 Adaptive changes within membrane fluidity following 
chronic incubation with antidepressants. 
In a following approach antidepressant medication was also tested for a 
possible adaptive impact on C6 cell membrane fluidity. For this purpose widely 
used antidepressants of distinct pharmacological mode of action and selectivity 
were applied. This were for once citalopram a selective serotonin reuptake 
inhibitor (SSRI), desipramine (DMI) a tricyclic antidepressant (TCA), and the 
Hypericum perforatum dried extract Ze117. Acute exposure with these 
antidepressants did not show a direct membrane interacting impact on 
membrane fluidity determined by unchanged DPH and TMA-DPH fluorescence 
anisotropy values. 
Chronic incubation with citalopram exposed no adaptive changes in C6 cell 
membrane fluidity, measured by DPH and TMA-DPH fluorescence anisotropy. 
This result correlated to the in parallel examined unchanged PC/PE ratio and 
unaffected choline-D9 incorporation rate into main PC species in whole C6 cell 
lipid extracts.  
An unchanged DPH and TMA-DPH fluorescence anisotropy was also described 
in rat brain plasma membranes after chronic oral citalopram treatment, which was 
however accompanied by a decreased PE content (Fišar et al., 2005).  
On the other side chronic incubation with DMI induced an adaptive increase in 
DPH fluorescence anisotropy in C6 cells, while TMA-DPH fluorescence 
anisotropy was unaffected. This increase in DPH fluorescence anisotropy stands 
opposite to the here examined decrease in DPH fluorescence anisotropy after 
chronic incubation with cortisol. Corresponding lipid analysis showed an 
unchanged PC/PE ratio, in accordance with the unaffected TMA-DPH 
fluorescence anisotropy. As the choline-D9 incorporation rate into main PC 
species was not changed after chronic DMI administration the examined 
decrease in membrane core fluidity measured by DPH fluorescence anisotropy 
may be the result of an increased cholesterol content or changed fatty acid profile 
within other phospholipid classes.  
Within a very similar chronic approach applying C6 cells incubated with 10 µM 
DMI did also not significantly change TMA-DPH fluorescence anisotropy, which 
shows consistency to own results (Bürgi, 2001). However chronic incubation with 
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10 µM DMI induced a significantly increased PC content and a nonsignificant 
decreased PE content (Bürgi, 2001). This increase in the PC/PE ratio may be the 
result of the ten times higher DMI concentration, where own observations in C6 
cells found only a nonsignificant tendency of an increased PC/PE ratio following 
chronic treatment with 1 µM DMI. Further own pulse-chase experiments excluded 
a changed PC content.  
However, literature indicates quite controversial effects of DMI on membrane 
fluidity and the PC/PE content, depending on cell type and experimental 
approach.  
Within ROC-1 cells, a very similar cell type (hybridoma clones between C6 rat 
glioblastoma cells + rat oligodendrocytes), 4 days of incubation with 5 µM DMI 
induced decrease in membrane fluidity however especially within superficial 
layers, which correlated to a significantly decreased PC/PE ratio (Toplak et al., 
1990). The change in membrane fluidity was measured by increased 
fluorescence anisotropy values of especially shorter n-(9-anthroyloxy) fatty acid 
analogues (Toplak et al., 1990). 
On the other side published in vivo approaches applying DMI long term treatment 
in rats describe only nonsignificant changes in the PC and PE content in brain 
homogenates (Moor et al., 1988) and in brain plasma membranes (Fišar et al., 
2005).  Parallel DPH and TMA-DPH fluorescence anisotropy measurements in 
rat brain plasma membranes showed no significant changes in membrane fluidity 
after chronic oral treatment with DMI (Fišar et al., 2005). However, the tendencies 
toward increasing the membrane fluidity were suggested by the authors to may 
be modulated at least in part by the cholesterol lowering effect of DMI (Fišar et 
al., 2005).  
In contrast to DMI, chronic incubation with Ze117 induced an adaptive membrane 
rigidification in C6 cells measured by both, DPH and TMA-DPH fluorescence 
anisotropy. The applied concentration range of 0.01 - 0.05 mg/ml Ze117 already 
showed a dose-dependent increase in fluorescence anisotropy values of both 
probes. Remarkably, this effect is opposite to the own described cortisol induced 
enhancement in C6 cell membrane fluidity, decreasing DPH and TMA-DPH 
florescence anisotropy.  
Within literature no comparable chronic approaches were found. However, 24 h 
incubation with a Hypericum perforatum extract has also been described to 
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mediate membrane rigidification in murine microglia (N11) cells, measured by 
pyrene fluorescence anisotropy (Kraus et al., 2007). Within an even shorter 
approach of only 3 hours after oral administration a decreasing tendency on 
DPH fluorescence anisotropy was examined in mice brain membranes (Eckert 
et al, 2004). This rather acute in vivo approach, however, may not necessarily 
be extrapolated on possible chronic long-term changes of membrane fluidity. 
The in addition performed pyrene measurements also showed only 
nonsignificant changes, which however showed the opposite direction toward 
reducing bulk-fluidity (hydrocarbon core) and annular-fluidity (reduced fluidity of 
lipids close to membrane proteins). The opposite effects within the hydrophobic 
core seen by DPH and pyrene were discussed by the authors as a result of 
distinct locations of the fluorescent probes within the membrane hydrophobic 
core. DPH locates itself parallel to the acyl chains in the center of the lipophilic 
bilayer leaflets, rather than the core, whereas pyrene is located directly at the 
terminal of the acyl chains within the bilayer core. The results therefore could 
be interpreted as decreased lateral diffusion accompanied by an increased 
rotational movement of the acyl chains (Eckert et al, 2004). While these changes 
in membrane fluidity did not reach significance after Hypericum perforatum 
extract (WS 5572) administration to mice, they did after oral hyperforin 
administration (Eckert et al., 2004). 
Available research clearly indicate various bioactive ingredients to contribute to 
the antidepressant effect of Hypericum perforatum extracts, often in a 
synergistic manner (Linde, 2009). The most interesting components hereby 
include hyperforin, hypericin and a broad range of flavonoid derivatives 
(Butterweck & Schmidt, 2007; Paulke et al., 2007).  
Applying HPLC analyses Ze117 was examined for the presence of such 
compounds and identified hyperforin, hypericin, pseudohypericin and several 
flavonoids including rutin, hyperoside, quercitrin, isoquercetin, quercetin, 
biapigenin and amentoflavone. From this spectrum of Ze117 ingredients 
hyperforin, hypericin, rutin, quercetin, biapigenin, and amentoflavone were 
chosen and tested for a contributing impact on adaptive C6 cell membrane 
rigidification.  
While no acute changes in DPH and TMA-DPH fluorescence anisotropy were 
observed, all substances, with the exception of rutin, showed to actually 
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participate in the adaptive dose-dependent membrane rigidification mediated by 
Ze117.  
The hereby observed membrane fluidity changes can be attributed to 
substances that all affect DPH fluorescence anisotropy with a varying impact on 
TMA-DPH fluorescence anisotropy. While hypericin increased DPH and TMA-
DPH fluorescence anisotropy values to a similar extend, hyperforin, quercetin 
and amentoflavone showed to have a comparable lower impact on TMA-DPH 
fluorescence anisotropy. Biapigenin, which differs from amentoflavone only by 
the coupling pattern of the two apigenin molecules, affected only DPH 
fluorescence anisotropy and failed to induce a significant change in TMA-DPH 
fluorescence anisotropy.  
For rutin, which differs from quercetin by an attached rutinose disaccharide and 
a therefore more hydrophilic character, no significant changes in DPH and 
TMA-DPH fluorescence anisotropy were found after chronic incubation with 
1 µM. However, a possible significant change in membrane fluidity applying a 
higher rutin concentration, as examined for amentoflavone at a concentration of 
1.5 µM, cannot be excluded. 
As the described substances show to act primary on the membrane core fluidity 
the sum effect of these constituents alone may already be responsible for the 
stronger impact on changing DPH fluorescence anisotropy compared to 
TMA-DPH following chronic incubation with the Ze117 extract. To the own 
knowledge this work present an adaptive chronic change in membrane fluidity 
mediated by constituents of Hypericum perforatum extracts for the first time.  
Approaching underlying lipidomic changes after chronic incubation with Ze117 
a dose-dependent decrease of the PC/PE ratio was found in C6 whole cell lipid 
extracts. This dose-dependent decrease of the PC/PE ratio probably contribute 
to the observed dose-dependent decrease in membrane fluidity, at least within 
the head group region. This Ze117 mediated impact on the PC/PE ratio is 
strongly suggested to be the result of changed enzymatic activity either within 
the biosynthesis or the degradation pathway, or both.   
Within this work a PC species specific reduced biosynthesis rate was identified 
applying parallel choline-D9 pulse-chase experiments, which contribute to the 
decreased PC/PE ratio in C6 cells after chronic Ze117 treatment.  
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While the incorporation of cholin-D9 into PC species bearing polyunsaturated 
fatty acids (18:3, 20:3, 20:4) was found to be unaffected, the de novo 
biosynthesis of PCs bearing a combination of only saturated and 
monounsaturated fatty acids was reduced after chronic incubation with Ze117. 
This affected PC species bearing a combination of 18:1, 16:1, 16:0 and possibly 
14:0 fatty acids.    
Although, this shift toward an increased PC-PUFA index would be associated 
with an increased membrane core fluidity, DPH fluorescence anisotropy 
measurements examined a decreased membrane core fluidity after chronic 
Ze117 treatment. This membrane fluidity increasing effect of the higher PUFA 
index is therefore suggested to be compensated at least in part by the tighter 
membrane packaging mediated by the reduced PC/PE ratio and a stronger 
intermolecular interaction associated with longer fatty acid chains. Further, the 
reduction of cis-configurated monounsaturated palmitoleic acid (16:1) and oleic 
acid (18:1), which bended tails disrupt tight packing and interaction of fatty 
acids, can also be associated with a reduced membrane fluidity (Vance & 
Vance, 2008; Pilch et al., 1980; Kitagawa et al. 1985).  
During PC de novo biosynthesis fatty acids incorporated into the sn-1 and sn-2 
position are generally saturated and monounsaturated fatty acids (Robichaud 
et al., 2013). The hereby converted diacylglycerol (DAG) molecule results from 
the interplay of different glycerol-3-phosphate acyltransferases (GPATs) and 
lysophospholipid acyltransferases (LPLATs). Rapid phospholipid remodulation 
and incorporation of PUFAs at the sn-2 position occurs after de novo 
biosynthesis, characterized by deacylation and subsequent reacylation 
catalyzed by a phospholipase A2 (PLA2) and a LPLAT (Farooqui et al., 2000; 
Shindou & Shimizu, 2009). The fatty acid released from the sn-2 position 
become again activated by a acyl-CoA synthetase (ACS) to produce acyl-CoA 
(Robichaud et al., 2013). 
As Ze117 mediates selective reduced cholin-D9 incorporation into PC species 
bearing saturated and monounsaturated acids but not PC species bearing a 
PUFA it may be suggested that possibly de-novo synthesis of PC is reduced in 
general while reacylation at the sn-2 position with PUFA is kept constant.   
However the interplay between phospholipid de novo and remodeling pathway 
is complex and poorly understood (Butler & Mallampalli, 2010). Overexpression 
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of lysophatidylcholine acyltransferase 1 (LPCAT1) has for example been 
reported to induce increased degradation of CPT1 
(cholinephosphotransferase 1), which catalyzes the final step for the PC de 
novo synthesis (Butler & Mallampalli, 2010). And hypericin mediated inhibition 
of protein kinase C (PKC), which increases catalytic PLA2-activity by 
phosphorylation, was described to inhibit PC biosynthesis in U937 cells (Chu, 
1994; Nemenoff et al., 1993). 
Several subtypes of GPAT, LPLAT, PLA2, and ACS with characteristic substrate 
specificities have been discovered and their differential expression is suggested 
to regulate tissue specific diversity of phospholipid molecular species 
(Robichaud et al., 2013; Shindou et al., 2015; Harayama et al., 2014).  
Interestingly hyperforin has been described to mediate enhanced cytosolic 
phospholipase A2 (cPLA2) activity in human platelets, which shows to prefer PC 
over PE (Hoffmann et al., 2010). Further cPLA2 cleaves preferentially long and 
polyunsaturated fatty acids, showing the highest affinity for arachidonic acid 
(20:4) containing phospholipids (Kramer & Sarp, 1997; Hoffmann et al., 2010).   
On the other side quercetin and amentoflavone have been reported to show an 
inhibitory effect on the selective type II phospholipase A2 (PLA2-type II) 
(Patočka, 2003; Lindahl & Tagesson 1997; Lindhal & Tagesson, 1993). The 
PLA2-type II is described to show a strong preference for negatively charged 
phospholipids including PE and PS, releasing a variety of unsaturated fatty 
acids (Diez et al., 1994; Freed et al., 1997; Snitko et al., 1997).  
In association to own results in C6 cells, those constituents which showed a 
chronic impact on membrane fluidity are highly suggested to modulate 
membrane lipid composition. The observed reduced synthesis of PC species 
bearing saturated and monounsaturated fatty acids can be suggested to result 
from down-regulation or inhibition of enzymes catalyzing the de-novo pathway.  
A theoretical hyperforin mediated enhanced hydrolysis of PC species bearing 
PUFA may be compensated by a generally increased turnover including an 
enhanced reacylation with PUFAs, keeping the amount of PUFA bearing PC 
species constant. This could be the result of enhanced acylation with a 
lysophosphocholine acyltransferase (LPCAT) like LPCAT2 which prefers 20:4 
acyl-CoAs as substrate (Shindou & Shimizu, 2009).  
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4.4 Conclusion and Outlook 
The presented findings regarding fluorescence anisotropy measurements 
applying DPH and TMA-DPH identified a membrane fluidity increasing effect in 
C6 cells stressed by chronic cortisol incubation. An opposite effect was found 
after chronic Ze117 treatment, which was identified to be mediated at least by the 
constituents hypericin, hyperforin, quercetin, amentoflavone and biapigenin. The 
tricyclic antidepressant DMI also showed to expose an adaptive decrease in 
membrane fluidity, however only in the membrane core as measured by 
increased DPH fluorescence anisotropy. Since membrane fluidity has a 
regulatory impact on membrane-associated receptor functioning, it can be 
suggested that the cortisol mediated adaptive changes in membrane fluidity 
contribute to the altered monoamine receptor signaling as described within 
depression. As Ze117 and in part DMI, showed an opposite adaptive effect 
compared to chronic cortisol treatment in C6 cells it may be assumed that this 
antidepressants may have a “normalizing” effect on the membrane fluidity of 
"stressed" cells and possibly on the functioning of membrane-associated 
receptors.  
In contrast to cortisol and DMI, chronic Ze117 incubation mediated changes in 
membrane fluidity at least in part by modulating the PC pool and PC/PE ratio. 
The hereby examined reduced synthesis of PC species bearing saturated and 
monounsaturated fatty acids may result from down-regulation or inhibition of 
enzymes catalyzing the de-novo pathway. This enzymes include choline kinase 
(CK), CTP:phosphocholine cytidylyltransferase (CCT) which catalyzes the rate-
limiting enzymatic step, and CDP-choline:1,2-diacylglycerol 
cholinephosphotransferase (CPT) which is mainly regulated by DAG availability 
(Gibellini & Smith, 2010).  Whereby DAG generation could also be modulated by 
downregulation of specific LPLATs and GPATs, like the 16:0 acyl-CoA preferring 
GPAT1 (Shindou & Shimizu, 2009). A theoretically reduced activity of LPCAT1 
and LPCAT4, which participate within the de-novo and the remodeling pathway, 
or limitation of their corresponding acyl-CoA substrate availability could also 
explain the reduced production of PC species bearing saturated and 
monounsaturated fatty acids. Hereby LPCAT1 has been reported to prefer 
saturated 16:0 acyl-CoAs (Butler & Mallampalli, 2010; Harayama et al., 2014), 
but also 18:1 acyl-CoA (Shindou & Shimizu, 2009) as a donor and 1-myristoyl 
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(14:0) or 1-palmitoyl (16:0) -lysoPC as an acceptor (Butler & Mallampalli, 2010). 
LPCAT4 (also named MBOAT2) plays a catalytic role with a preference for 16:1- 
and 18:1 acyl-CoA within the PC synthesis (Kurabe et al., 2013; Harayama et al., 
2014; Hishikawa et al., 2008; Shindou & Shimizu, 2009).  
It must be assumed that several bioactive ingredients of Ze117 participate in the 
modulation of the phospholipid composition by various mechanisms targeting at 
least the PC de-novo synthesis and the fatty acid remodeling pathway.  Within 
this context several specific PLA2 activity regulating effects have been described 
in literature for at least hyperforin, hypericin, quercetin and amentoflavone 
(Hoffmann et al., 2010; Chu, 1994; Patočka, 2003; Lindahl & Tagesson 1997). 
Within future approaches the impact of Ze117 and individual constituents on de-
novo catalyzing enzymes as well as their interplay with selective subtypes of 
GPAT, LPLAT, PLA2, and ACS, with characteristic substrate specificities, may 
be considered. 
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6  Appendix 
  
Figure 6.1: MS spectra of PC-pairs identification in whole cell lipid extracts after 
choline-D9 exposure to C6 cells. The incorporation of choline-D9 into PC via the de-
novo biosynthesis pathway results in the appearance of deuterated PC derivatives (red) 
of corresponding natural occurring PC species (blue)(A). Each pair with the mass shift 
of 9 was proven to represent the deuterated derivative and the natural occurring PC 
species by forming at least an identical DAG-like fragment after MS2 fragmentation (B). 
A) 
B) 
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Figure 6.2: Negative mode MS spectra of PC species identification applying 
anionic PC adducts. Main PC species previously investigated at positive mode as 
[M+H]+ cations are detected within the negative mode as anionic chloride [M+Cl]- or 
acetate [M+CH3COO]- adduct. Corresponding MS3 fragmentation results in the 
identification of attached fatty acids. The sn-2 fatty acid fragment [R2COO]- is 
distinguished from the sn-1 fatty acid fragment [R1COO]-  due to it appears with a higher 
abundancy.  
 
 
 
 
                                                                                                                                                         Appendix 
70 
 
 
Eidesstattliche Erklärung 
Hiermit versichere ich, Nelli Keksel, dass ich die vorliegende Arbeit selbstständig 
angefertigt und keine anderen als die angegebenen Hilfsmittel und Quellen 
benutzt habe. Ferner erkläre ich, die vorliegende Arbeit an keiner anderen 
Hochschule als Dissertation eingereicht zu haben. Ich habe noch keinen 
Promotionsversuch unternommen. Die Ergebnisse dieser Dissertation sind an 
den aufgeführten Stellen auszugsweise veröffentlicht. 
 
 
Bonn, Datum __________   Unterschrift ____________ 
 
 
Publikationen und Beiträge auf Fachkongressen  
 
Publikation: N. Keksel, H. Bußmann, M. Unger, J. Drewe, G. Boonen, S. 
Franken, H. Häberlein. „ St John´s wort extract influences membrane fluidity and 
composition of phosphatidylcholine and phosphatidylethanolamine in rat C6 
glioblastoma cells”. Akzeptiert bei Phytomedicine. 
Publikation: D. K. Glatzel, A. Koeberle, H. Pein, K. Loeser, A. Stark, N. Keksel, 
O. Werz, R. Müller, I. Bischoff, R. Fürst. „ Acetyl-CoA carboxylase 1 regulates 
endothelial cell migration by shifting the phospholipid composition.” Journal of 
Lipid Research, 59(2), 298-311, 2018. 
Vortrag: N. Keksel, H. Bußmann, M. Unger, J. Drewe, G. Boonen, S. Franken, 
H. Häberlein.„Influence of the St, John´s wort extract Ze117 on membrane fluidity, 
signal transduction, and mobility of the β-adrenergic receptor.” 65. internationaler 
Kongress der Gesellschaft für Arzneipflanzen- und Naturstoff-Forschung e.V. 
(GA) in Basel, Schweiz. 2017   
Poster: D. K. Glatzel, N. Keksel, A. Koeberle, O.  Werz, M. Ashtikar, R. Müller, 
R. Fürst. „The acetyl-CoA carboxylase (ACC) inhibitor soraphen blocks the 
proliferation and migration of primary endothelial cells.”  29. Irseer Naturstofftage 
der Gesellschaft für Chemische Technik und Biotechnologie e.V. (DECHEMA) in 
Irseer, Deutschland. 2017 
 
Publikation: C. Greunke, A. Hage-Hülsmann, T. Sorkalla, N. Keksel, F. 
Häberlein , H. Häberlein. „ A systematic study on the influence of the main 
ingredients of an ivy leaves dry extract on the β2-adrenergic responsiveness of 
human airway smooth muscle cells.” Pulmonary Pharmacology & Therapeutics, 
31, 92-98, 2015. 
 
                                                                                                                                                         Appendix 
71 
 
 
 
                                                                     Danksagungen  
 
Zuerst möchte mich ganz herzlich bei Herrn Prof. Dr. Hanns Häberlein für die 
Ermöglichung dieser Arbeit und die großzügigen Arbeitsbedingungen 
bedanken.  
 
Darüber  hinaus bedanke ich mich vielmals bei Prof. Dr. Hanns Häberlein und 
Dr. Sebastian Franken für die stets vorhandene Betreuung und tatkräftige 
Unterstützung, die wesentlich zum Gelingen dieser Arbeit beigetragen hat.  
 
Zusätzlich möchte ich mich noch bei Dr. Sebastian Franken für die tollen Ideen 
bei der Entwicklung und die Unterstützung bei der Umsetzung der 
Massenspektrometrieanalysen bedanken.  Hierbei auch meinen Dank an Dr. 
Marc Sylvester und Bernd Gehrig, die ebenfalls mit ihrem Know-how zur Seite 
standen. 
 
Ein weiterer großer Dank geht an Herrn Prof. Dr. Christoph Thiele für die 
Übernahme des Koreferats und die Möglichkeit der Promotion im Fachbereich 
Molekulare Biomedizin. Für seine Bereitschaft, sich mehrfach mit dem 
Voranschreiten der Arbeit auseinanderzusetzen und dem guten Rat, die 
Fettsäureidentifizierung mittels anionischer PC-Addukte anzugehen, möchte ich 
mich ebenfalls bedanken.  
 
Ich danke Prof. Dr. Kubitscheck  und Dr. Jan-Peter Siebrasse für die 
Möglichkeit, die Fluoreszenzanisotropiemessungen im Institut für Physikalische 
und Theoretische Chemie durchzuführen zu können. Ich wurde dort freundlich 
aufgenommen und unterstützt. 
 
Bei Dr. Georg Boonen, Prof. Dr. Jürgen Drewe und Dr. habil. Matthias Unger 
von der Max Zeller Sohne AG in Romanshorn, Schweiz, bedanke ich mich für 
die finanzielle Unterstützung und das große Interesse an der Thematik.  
 
Allen Mitarbeitern der Arbeitsgruppe Häberlein danke ich für den stets 
freundschaftlichen Umgang und die tolle Arbeitsatmosphäre. Es war sehr lustig 
mit euch! 
